| |
UNITED
STATES
SECURITIES AND EXCHANGE
COMMISSION
Washington, D.C. 20549 |
OMB
APPROVAL |
| |
OMB Number: 3235-0582 |
| |
Expires: July 31, 2024 |
| |
Estimated average burden |
| |
hours per response........4 |
FORM N-PX
ANNUAL REPORT OF PROXY VOTING RECORD OF REGISTERED
MANAGEMENT INVESTMENT COMPANY
Investment Company Act file number 811-06565
Tekla Healthcare Opportunites Fund
(Exact name of registrant as specified in charter)
| 100
Federal Street, 19th Floor, Boston, MA |
|
02110 |
| (Address
of principal executive offices) |
|
(Zip
code) |
Laura Woodward
Tekla Healthcare Opportunities Fund
100
Federal Street, 19th Floor, Boston MA 02110
(Name and address of agent for service)
Registrant’s telephone number, including area code: 617-772-8500
Date
of fiscal year end: September 30
Date
of reporting period: 7/1/22-6/30/23
Form N-PX is to be used by a registered management
investment company, other than a small business investment company registered on Form N-5 (ss.ss. 239.24 and 274.5 of this chapter),
to file reports with the Commission, no later than August 31 of each year, containing the registrant’s proxy voting record
for the most recent twelve-month period ended June 30, pursuant to section 30 of the Investment Company Act of 1940 and rule 30b1-4
thereunder (17 CFR 270.30b1-4). The Commission may use the information provided on Form N-PX in its regulatory, disclosure review,
inspection, and policymaking roles.
A registrant is required to disclose the information
specified by Form N-PX, and the Commission will make this information public. A registrant is not required to respond to the collection
of information contained in Form N-PX unless the Form displays a currently valid Office of Management and Budget (“OMB”)
control number. Please direct comments concerning the accuracy of the information collection burden estimate and any suggestions for
reducing the burden to the Secretary, Securities and Exchange Commission, 450 Fifth Street, NW, Washington, DC 20549-0609. The OMB has
reviewed this collection of information under the clearance requirements of 44 U.S.C. ss. 3507.
Item 1. Proxy Voting Record.
Vote Summary
1LIFE HEALTHCARE, INC.
| Security |
68269G107 |
Meeting Type |
Special |
| Ticker Symbol |
ONEM |
Meeting Date |
22-Sep-2022 |
| Record Date |
22-Aug-2022 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1. |
|
To adopt the Agreement
and Plan of Merger, dated July 20, 2022 (such agreement, as it may be amended, modified or supplemented from time to time, the "Merger
Agreement"), by and among 1Life Healthcare, Inc. ("1Life"), a Delaware corporation, Amazon.com, Inc. ("Amazon"),
a Delaware corporation, and Negroni Merger Sub, Inc. ("Merger Sub"), a Delaware corporation. Upon the terms and subject
to the conditions of the Merger Agreement, Amazon will acquire 1Life via a merger of Merger Sub with and into 1Life, with 1Life continuing
as the surviving corporation. |
|
Management |
|
For |
|
For |
|
| 2. |
|
To approve, on an advisory
(non-binding) basis, the compensation that may be paid or become payable to 1Life's named executive officers that is based on or
otherwise relates to the Merger Agreement and the transactions contemplated by the Merger Agreement. |
|
Management |
|
For |
|
For |
|
| 3. |
|
To adjourn the special
meeting of the 1Life stockholders (the "Special Meeting") to a later date or dates, if necessary or appropriate, including
to solicit additional proxies to approve the proposal to adopt the Merger Agreement if there are insufficient votes to adopt the
Merger Agreement at the time of the Special Meeting. |
|
Management |
|
For |
|
For |
|
ABBOTT LABORATORIES
| Security |
002824100 |
Meeting Type |
Annual |
| Ticker Symbol |
ABT |
Meeting Date |
28-Apr-2023 |
| Record Date |
01-Mar-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a. |
|
Election of Director: R.
J. Alpern |
|
Management |
|
For |
|
For |
|
| 1b. |
|
Election of Director: C.
Babineaux-Fontenot |
|
Management |
|
For |
|
For |
|
| 1c. |
|
Election of Director: S.
E. Blount |
|
Management |
|
For |
|
For |
|
| 1d. |
|
Election of Director: R.
B. Ford |
|
Management |
|
For |
|
For |
|
| 1e. |
|
Election of Director: P.
Gonzalez |
|
Management |
|
For |
|
For |
|
| 1f. |
|
Election of Director: M.
A. Kumbier |
|
Management |
|
For |
|
For |
|
| 1g. |
|
Election of Director: D.
W. McDew |
|
Management |
|
For |
|
For |
|
| 1h. |
|
Election of Director: N.
McKinstry |
|
Management |
|
For |
|
For |
|
| 1i. |
|
Election of Director: M.
G. O'Grady |
|
Management |
|
For |
|
For |
|
| 1j. |
|
Election of Director: M.
F. Roman |
|
Management |
|
For |
|
For |
|
| 1k. |
|
Election of Director: D.
J. Starks |
|
Management |
|
For |
|
For |
|
| 1l. |
|
Election of Director: J.
G. Stratton |
|
Management |
|
For |
|
For |
|
| 2. |
|
Ratification of Ernst &
Young LLP As Auditors |
|
Management |
|
For |
|
For |
|
| 3. |
|
Say on Pay - An Advisory
Vote on the Approval of Executive Compensation |
|
Management |
|
For |
|
For |
|
| 4. |
|
Say When on Pay - An Advisory
Vote on the Approval of the Frequency of Shareholder Votes on Executive Compensation |
|
Management |
|
1 Year |
|
For |
|
| 5. |
|
Shareholder Proposal -
Special Shareholder Meeting Threshold |
|
Shareholder |
|
Against |
|
For |
|
| 6. |
|
Shareholder Proposal -
Independent Board Chairman |
|
Shareholder |
|
Against |
|
For |
|
| 7. |
|
Shareholder Proposal -
Lobbying Disclosure |
|
Shareholder |
|
Against |
|
For |
|
| 8. |
|
Shareholder Proposal -
Incentive Compensation |
|
Shareholder |
|
Against |
|
For |
|
ABBVIE INC.
| Security |
00287Y109 |
Meeting Type |
Annual |
| Ticker Symbol |
ABBV |
Meeting Date |
05-May-2023 |
| Record Date |
06-Mar-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a. |
|
Election of Class II Director:
Robert J. Alpern |
|
Management |
|
For |
|
For |
|
| 1b. |
|
Election of Class II Director:
Melody B. Meyer |
|
Management |
|
For |
|
For |
|
| 1c. |
|
Election of Class II Director:
Frederick H. Waddell |
|
Management |
|
For |
|
For |
|
| 2. |
|
Ratification of Ernst &
Young LLP as AbbVie's independent registered public accounting firm for 2023. |
|
Management |
|
For |
|
For |
|
| 3. |
|
Say on Pay - An advisory
vote on the approval of executive compensation. |
|
Management |
|
For |
|
For |
|
| 4. |
|
Approval of a management
proposal regarding amendment of the certificate of incorporation to eliminate supermajority voting. |
|
Management |
|
For |
|
For |
|
| 5. |
|
Stockholder Proposal -
to Implement Simple Majority Vote. |
|
Shareholder |
|
Against |
|
For |
|
| 6. |
|
Stockholder Proposal -
to Issue an Annual Report on Political Spending. |
|
Shareholder |
|
Against |
|
For |
|
| 7. |
|
Stockholder Proposal -
to Issue an Annual Report on Lobbying. |
|
Shareholder |
|
Against |
|
For |
|
| 8. |
|
Stockholder Proposal -
to Issue a Report on Patent Process. |
|
Shareholder |
|
Against |
|
For |
|
ACADIA HEALTHCARE COMPANY, INC.
| Security |
00404A109 |
Meeting Type |
Annual |
| Ticker Symbol |
ACHC |
Meeting Date |
18-May-2023 |
| Record Date |
23-Mar-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a. |
|
Election of Director: Michael
J. Fucci |
|
Management |
|
For |
|
For |
|
| 1b. |
|
Election of Director: Wade
D. Miquelon |
|
Management |
|
For |
|
For |
|
| 2. |
|
Approve an amendment and
restatement of the Acadia Healthcare Company, Inc. Incentive Compensation Plan as presented in the Proxy Statement. |
|
Management |
|
For |
|
For |
|
| 3. |
|
Advisory vote on the compensation
of the Company's named executive officers as presented in the Proxy Statement. |
|
Management |
|
For |
|
For |
|
| 4. |
|
Ratify the appointment
of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2023. |
|
Management |
|
For |
|
For |
|
AGILENT TECHNOLOGIES, INC.
| Security |
00846U101 |
Meeting Type |
Annual |
| Ticker Symbol |
A |
Meeting Date |
15-Mar-2023 |
| Record Date |
24-Jan-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1.1 |
|
Election of Director for
a three-year term: Heidi K. Kunz |
|
Management |
|
For |
|
For |
|
| 1.2 |
|
Election of Director for
a three-year term: Susan H. Rataj |
|
Management |
|
For |
|
For |
|
| 1.3 |
|
Election of Director for
a three-year term: George A. Scangos, Ph.D. |
|
Management |
|
For |
|
For |
|
| 1.4 |
|
Election of Director for
a three-year term: Dow R. Wilson |
|
Management |
|
For |
|
For |
|
| 2. |
|
To approve, on a non-binding
advisory basis, the compensation of our named executive officers. |
|
Management |
|
For |
|
For |
|
| 3. |
|
To ratify the Audit and
Finance Committee's appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm. |
|
Management |
|
For |
|
For |
|
| 4. |
|
To approve amendments to
the Certificate of Incorporation to create a new stockholder right to call a special meeting. |
|
Management |
|
For |
|
For |
|
| 5. |
|
An advisory vote on the
frequency of the stockholder vote to approve the compensation of our named executive officers. |
|
Management |
|
1 Year |
|
For |
|
ALIGN TECHNOLOGY, INC.
| Security |
016255101 |
Meeting Type |
Annual |
| Ticker Symbol |
ALGN |
Meeting Date |
17-May-2023 |
| Record Date |
23-Mar-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1.1 |
|
Election of Director: Kevin
J. Dallas |
|
Management |
|
For |
|
For |
|
| 1.2 |
|
Election of Director: Joseph
M. Hogan |
|
Management |
|
For |
|
For |
|
| 1.3 |
|
Election of Director: Joseph
Lacob |
|
Management |
|
For |
|
For |
|
| 1.4 |
|
Election of Director: C.
Raymond Larkin, Jr. |
|
Management |
|
For |
|
For |
|
| 1.5 |
|
Election of Director: George
J. Morrow |
|
Management |
|
For |
|
For |
|
| 1.6 |
|
Election of Director: Anne
M. Myong |
|
Management |
|
For |
|
For |
|
| 1.7 |
|
Election of Director: Andrea
L. Saia |
|
Management |
|
For |
|
For |
|
| 1.8 |
|
Election of Director: Susan
E. Siegel |
|
Management |
|
For |
|
For |
|
| 2. |
|
AMENDMENT TO AMENDED AND
RESTATED CERTIFICATE OF INCORPORATION: Proposal to approve the amendment to our Amended and Restated Certificate of Incorporation
to reflect new Delaware law provisions regarding officer exculpation. |
|
Management |
|
For |
|
For |
|
| 3. |
|
ADVISORY VOTE ON NAMED
EXECUTIVES COMPENSATION: Consider an Advisory Vote to Approve the Compensation of our Named Executive Officers. |
|
Management |
|
For |
|
For |
|
| 4. |
|
ADVISORY VOTE ON FREQUENCY
OF STOCKHOLDERS' APPROVAL OF EXECUTIVES COMPENSATION: Consider an Advisory Vote to Approve the Frequency of Stockholders Advisory
Vote on Named Executive Officers' Compensation. |
|
Management |
|
1 Year |
|
For |
|
| 5. |
|
AMENDMENT TO INCENTIVE
PLAN: Approve the Amendment to our 2005 Incentive Plan. |
|
Management |
|
For |
|
For |
|
| 6. |
|
RATIFICATION OF APPOINTMENT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTANTS: Proposal to ratify the appointment of PricewaterhouseCoopers LLP as Align Technology,
Inc.'s independent registered public accountants for the fiscal year ending December 31, 2023. |
|
Management |
|
For |
|
For |
|
AMEDISYS, INC.
| Security |
023436108 |
Meeting Type |
Annual |
| Ticker Symbol |
AMED |
Meeting Date |
08-Jun-2023 |
| Record Date |
11-Apr-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1. |
|
DIRECTOR |
|
Management |
|
|
|
|
|
| |
|
1 |
Richard M.
Ashworth |
|
|
|
For |
|
For |
|
| |
|
2 |
Vickie L. Capps |
|
|
|
For |
|
For |
|
| |
|
3 |
Molly J. Coye, MD |
|
|
|
For |
|
For |
|
| |
|
4 |
Julie D. Klapstein |
|
|
|
For |
|
For |
|
| |
|
5 |
Teresa L. Kline |
|
|
|
For |
|
For |
|
| |
|
6 |
Paul B. Kusserow |
|
|
|
For |
|
For |
|
| |
|
7 |
Bruce D. Perkins |
|
|
|
For |
|
For |
|
| |
|
8 |
Jeffery A. Rideout, MD |
|
|
|
For |
|
For |
|
| |
|
9 |
Ivanetta Davis Samuels |
|
|
|
For |
|
For |
|
| 2. |
|
To ratify the
appointment of KPMG LLP as the Company's independent registered public accountants for the fiscal year ending December 31, 2023. |
|
Management |
|
For |
|
For |
|
| 3. |
|
To approve,
on an advisory (non-binding) basis, the compensation paid to the Company's Named Executive Officers, as set forth in the Company's
2023 Proxy Statement ("Say on Pay" Vote). |
|
Management |
|
For |
|
For |
|
| 4. |
|
To approve,
on an advisory (non-binding) basis, the frequency of future stockholder Say on Pay Votes. |
|
Management |
|
1 Year |
|
For |
|
AMERISOURCEBERGEN CORPORATION
| Security |
03073E105 |
Meeting Type |
Annual |
| Ticker Symbol |
ABC |
Meeting Date |
09-Mar-2023 |
| Record Date |
09-Jan-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a. |
|
Election of Director: Ornella
Barra |
|
Management |
|
For |
|
For |
|
| 1b. |
|
Election of Director: Steven
H. Collis |
|
Management |
|
For |
|
For |
|
| 1c. |
|
Election of Director: D.
Mark Durcan |
|
Management |
|
For |
|
For |
|
| 1d. |
|
Election of Director: Richard
W. Gochnauer |
|
Management |
|
For |
|
For |
|
| 1e. |
|
Election of Director: Lon
R. Greenberg |
|
Management |
|
For |
|
For |
|
| 1f. |
|
Election of Director: Kathleen
W. Hyle |
|
Management |
|
For |
|
For |
|
| 1g. |
|
Election of Director: Lorence
H. Kim, M.D. |
|
Management |
|
For |
|
For |
|
| 1h. |
|
Election of Director: Henry
W. McGee |
|
Management |
|
For |
|
For |
|
| 1i. |
|
Election of Director: Redonda
G. Miller, M.D. |
|
Management |
|
For |
|
For |
|
| 1j. |
|
Election of Director: Dennis
M. Nally |
|
Management |
|
For |
|
For |
|
| 2. |
|
Ratification of Ernst &
Young LLP as the Company's independent registered public accounting firm for fiscal year 2023. |
|
Management |
|
For |
|
For |
|
| 3. |
|
Advisory vote to approve
the compensation of the Company's named executive officers. |
|
Management |
|
For |
|
For |
|
| 4. |
|
Advisory vote on the frequency
of a shareholder vote on the compensation of the Company's named executive officers. |
|
Management |
|
1 Year |
|
For |
|
| 5. |
|
Shareholder proposal regarding
shareholder ratification of termination pay. |
|
Shareholder |
|
Against |
|
For |
|
AMGEN INC.
| Security |
031162100 |
Meeting Type |
Annual |
| Ticker Symbol |
AMGN |
Meeting Date |
19-May-2023 |
| Record Date |
20-Mar-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a. |
|
Election of Director for
a term of office expiring at the 2024 annual meeting: Dr. Wanda M. Austin |
|
Management |
|
For |
|
For |
|
| 1b. |
|
Election of Director for
a term of office expiring at the 2024 annual meeting: Mr. Robert A. Bradway |
|
Management |
|
For |
|
For |
|
| 1c. |
|
Election of Director for
a term of office expiring at the 2024 annual meeting: Dr. Michael V. Drake |
|
Management |
|
For |
|
For |
|
| 1d. |
|
Election of Director for
a term of office expiring at the 2024 annual meeting: Dr. Brian J. Druker |
|
Management |
|
For |
|
For |
|
| 1e. |
|
Election of Director for
a term of office expiring at the 2024 annual meeting: Mr. Robert A. Eckert |
|
Management |
|
For |
|
For |
|
| 1f. |
|
Election of Director for
a term of office expiring at the 2024 annual meeting: Mr. Greg C. Garland |
|
Management |
|
For |
|
For |
|
| 1g. |
|
Election of Director for
a term of office expiring at the 2024 annual meeting: Mr. Charles M. Holley, Jr. |
|
Management |
|
For |
|
For |
|
| 1h. |
|
Election of Director for
a term of office expiring at the 2024 annual meeting: Dr. S. Omar Ishrak |
|
Management |
|
For |
|
For |
|
| 1i. |
|
Election of Director for
a term of office expiring at the 2024 annual meeting: Dr. Tyler Jacks |
|
Management |
|
For |
|
For |
|
| 1j. |
|
Election of Director for
a term of office expiring at the 2024 annual meeting: Ms. Ellen J. Kullman |
|
Management |
|
For |
|
For |
|
| 1k. |
|
Election of Director for
a term of office expiring at the 2024 annual meeting: Ms. Amy E. Miles |
|
Management |
|
For |
|
For |
|
| 1l. |
|
Election of Director for
a term of office expiring at the 2024 annual meeting: Dr. Ronald D. Sugar |
|
Management |
|
For |
|
For |
|
| 1m. |
|
Election of Director for
a term of office expiring at the 2024 annual meeting: Dr. R. Sanders Williams |
|
Management |
|
For |
|
For |
|
| 2. |
|
Advisory vote on the frequency
of future stockholder advisory votes to approve executive compensation. |
|
Management |
|
1 Year |
|
For |
|
| 3. |
|
Advisory vote to approve
our executive compensation. |
|
Management |
|
For |
|
For |
|
| 4. |
|
To ratify the selection
of Ernst & Young LLP as our independent registered public accountants for the fiscal year ending December 31, 2023. |
|
Management |
|
For |
|
For |
|
ARGENX SE
| Security |
04016X101 |
Meeting Type |
Special |
| Ticker Symbol |
ARGX |
Meeting Date |
12-Dec-2022 |
| Record Date |
08-Nov-2022 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 2. |
|
Appointment of Ana Cespedes
as non-executive director to the board of directors of the Company |
|
Management |
|
Abstain |
|
|
|
ARGENX SE
| Security |
04016X101 |
Meeting Type |
Annual |
| Ticker Symbol |
ARGX |
Meeting Date |
02-May-2023 |
| Record Date |
04-Apr-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 3. |
|
Advisory vote to approve
the 2022 remuneration report. |
|
Management |
|
For |
|
|
|
| 4b. |
|
Adoption of the 2022 annual
accounts. |
|
Management |
|
For |
|
|
|
| 4d. |
|
Allocation of losses of
the Company in the financial year 2021 to the retained earnings of the Company. |
|
Management |
|
For |
|
|
|
| 4e. |
|
Proposal to release the
members of the board of directors from liability for their respective duties carried out in the financial year 2022. |
|
Management |
|
For |
|
|
|
| 5. |
|
Proposal to re-appoint
Don deBethizy as non-executive director for a term of two years. |
|
Management |
|
For |
|
|
|
| 6. |
|
Authorization of the board
of directors to issue shares and grant rights to subscribe for shares in the share capital of the Company up to a maximum of 10%
of the outstanding capital at the date of the general meeting, for a period of 18 months from the annual general meeting and to limit
or exclude statutory pre-emptive rights, if any. |
|
Management |
|
For |
|
|
|
| 7. |
|
Appointment of Deloitte
Accountants B.V. as statutory auditor for the 2023 financial year. |
|
Management |
|
For |
|
|
|
ARISTEA THERAPEUTICS, INC.
| Security |
N/A |
Meeting Type |
Written Consent |
| Ticker Symbol |
N/A |
Meeting Date |
7-Jul-2022 |
| Record Date |
N/A |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1. |
|
Appoint Independent director |
|
Management |
|
For |
|
For |
|
ARISTEA THERAPEUTICS, INC.
| Security |
N/A |
Meeting Type |
Written Consent |
| Ticker Symbol |
N/A |
Meeting Date |
7-Jul-2022 |
| Record Date |
N/A |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1. |
|
Appoint Series A director |
|
Management |
|
For |
|
For |
|
ASSERTIO HOLDINGS, INC.
| Security |
04546C205 |
Meeting Type |
Annual |
| Ticker Symbol |
ASRT |
Meeting Date |
10-May-2023 |
| Record Date |
31-Mar-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1.1 |
|
Election of Director to
serve until the 2024 Annual Meeting of Stockholders: Heather L. Mason |
|
Management |
|
For |
|
For |
|
| 1.2 |
|
Election of Director to
serve until the 2024 Annual Meeting of Stockholders: William T. McKee |
|
Management |
|
For |
|
For |
|
| 1.3 |
|
Election of Director to
serve until the 2024 Annual Meeting of Stockholders: Daniel A. Peisert |
|
Management |
|
For |
|
For |
|
| 1.4 |
|
Election of Director to
serve until the 2024 Annual Meeting of Stockholders: Peter D. Staple |
|
Management |
|
For |
|
For |
|
| 1.5 |
|
Election of Director to
serve until the 2024 Annual Meeting of Stockholders: James L. Tyree |
|
Management |
|
For |
|
For |
|
| 2. |
|
To approve an amendment
and restatement of the Company's Amended and Restated 2014 Omnibus Incentive Plan to increase the number of shares available for
issuance thereunder. |
|
Management |
|
For |
|
For |
|
| 3. |
|
To approve, on an advisory
basis, the compensation of the Company's named executive officers. |
|
Management |
|
For |
|
For |
|
| 4. |
|
To conduct, on an advisory
basis, a vote on the preferred frequency of future advisory votes to approve the compensation of the Company's named executive officers. |
|
Management |
|
1 Year |
|
For |
|
| 5. |
|
To approve an amendment
to the Amended and Restated Certificate of Incorporation of Assertio Therapeutics, Inc., a wholly-owned subsidiary of the Company,
to eliminate the pass-through voting provision. |
|
Management |
|
For |
|
For |
|
| 6. |
|
To ratify the appointment
of Grant Thornton LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2023. |
|
Management |
|
For |
|
For |
|
ASTRAZENECA PLC
| Security |
046353108 |
Meeting Type |
Annual |
| Ticker Symbol |
AZN |
Meeting Date |
27-Apr-2023 |
| Record Date |
10-Mar-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1. |
|
To receive the Company's
Accounts, the Reports of the Directors and Auditor and the Strategic Report for the year ended 31 December 2022 |
|
Management |
|
For |
|
For |
|
| 2. |
|
To confirm dividends |
|
Management |
|
For |
|
For |
|
| 3. |
|
To reappoint PricewaterhouseCoopers
LLP as Auditor |
|
Management |
|
For |
|
For |
|
| 4. |
|
To authorise the Directors
to agree the remuneration of the Auditor |
|
Management |
|
For |
|
For |
|
| 5a. |
|
Re-election of Director:
Michel Demaré |
|
Management |
|
For |
|
For |
|
| 5b. |
|
Re-election of Director:
Pascal Soriot |
|
Management |
|
For |
|
For |
|
| 5c. |
|
Re-election of Director:
Aradhana Sarin |
|
Management |
|
For |
|
For |
|
| 5d. |
|
Re-election of Director:
Philip Broadley |
|
Management |
|
For |
|
For |
|
| 5e. |
|
Re-election of Director:
Euan Ashley |
|
Management |
|
For |
|
For |
|
| 5f. |
|
Re-election of Director:
Deborah DiSanzo |
|
Management |
|
For |
|
For |
|
| 5g. |
|
Re-election of Director:
Diana Layfield |
|
Management |
|
For |
|
For |
|
| 5h. |
|
Re-election of Director:
Sheri McCoy |
|
Management |
|
For |
|
For |
|
| 5i. |
|
Re-election of Director:
Tony Mok |
|
Management |
|
For |
|
For |
|
| 5j. |
|
Re-election of Director:
Nazneen Rahman |
|
Management |
|
For |
|
For |
|
| 5k. |
|
Re-election of Director:
Andreas Rummelt |
|
Management |
|
For |
|
For |
|
| 5l. |
|
Re-election of Director:
Marcus Wallenberg |
|
Management |
|
For |
|
For |
|
| 6. |
|
To approve the Annual Report
on Remuneration for the year ended 31 December 2022 |
|
Management |
|
For |
|
For |
|
| 7. |
|
To authorise limited political
donations |
|
Management |
|
For |
|
For |
|
| 8. |
|
To authorise the Directors
to allot shares |
|
Management |
|
For |
|
For |
|
| 9. |
|
To authorise the Directors
to disapply pre-emption rights (Special Resolution) |
|
Management |
|
For |
|
For |
|
| 10. |
|
To authorise the Directors
to further disapply pre-emption rights for acquisitions and specified capital investments (Special Resolution) |
|
Management |
|
For |
|
For |
|
| 11. |
|
To authorise the Company
to purchase its own shares (Special Resolution) |
|
Management |
|
For |
|
For |
|
| 12. |
|
To reduce the notice period
for general meetings (Special Resolution) |
|
Management |
|
For |
|
For |
|
| 13. |
|
To adopt new Articles of
Association (Special Resolution) |
|
Management |
|
For |
|
For |
|
ASTRAZENECA PLC
| Security |
046353108 |
Meeting Type |
Annual |
| Ticker Symbol |
AZN |
Meeting Date |
27-Apr-2023 |
| Record Date |
04-Apr-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1. |
|
To receive the Company's
Accounts, the Reports of the Directors and Auditor and the Strategic Report for the year ended 31 December 2022 |
|
Management |
|
For |
|
For |
|
| 2. |
|
To confirm dividends |
|
Management |
|
For |
|
For |
|
| 3. |
|
To reappoint PricewaterhouseCoopers
LLP as Auditor |
|
Management |
|
For |
|
For |
|
| 4. |
|
To authorise the Directors
to agree the remuneration of the Auditor |
|
Management |
|
For |
|
For |
|
| 5a. |
|
Re-election of Director:
Michel Demaré |
|
Management |
|
For |
|
For |
|
| 5b. |
|
Re-election of Director:
Pascal Soriot |
|
Management |
|
For |
|
For |
|
| 5c. |
|
Re-election of Director:
Aradhana Sarin |
|
Management |
|
For |
|
For |
|
| 5d. |
|
Re-election of Director:
Philip Broadley |
|
Management |
|
For |
|
For |
|
| 5e. |
|
Re-election of Director:
Euan Ashley |
|
Management |
|
For |
|
For |
|
| 5f. |
|
Re-election of Director:
Deborah DiSanzo |
|
Management |
|
For |
|
For |
|
| 5g. |
|
Re-election of Director:
Diana Layfield |
|
Management |
|
For |
|
For |
|
| 5h. |
|
Re-election of Director:
Sheri McCoy |
|
Management |
|
For |
|
For |
|
| 5i. |
|
Re-election of Director:
Tony Mok |
|
Management |
|
For |
|
For |
|
| 5j. |
|
Re-election of Director:
Nazneen Rahman |
|
Management |
|
For |
|
For |
|
| 5k. |
|
Re-election of Director:
Andreas Rummelt |
|
Management |
|
For |
|
For |
|
| 5l. |
|
Re-election of Director:
Marcus Wallenberg |
|
Management |
|
For |
|
For |
|
| 6. |
|
To approve the Annual Report
on Remuneration for the year ended 31 December 2022 |
|
Management |
|
For |
|
For |
|
| 7. |
|
To authorise limited political
donations |
|
Management |
|
For |
|
For |
|
| 8. |
|
To authorise the Directors
to allot shares |
|
Management |
|
For |
|
For |
|
| 9. |
|
To authorise the Directors
to disapply pre-emption rights (Special Resolution) |
|
Management |
|
For |
|
For |
|
| 10. |
|
To authorise the Directors
to further disapply pre-emption rights for acquisitions and specified capital investments (Special Resolution) |
|
Management |
|
For |
|
For |
|
| 11. |
|
To authorise the Company
to purchase its own shares (Special Resolution) |
|
Management |
|
For |
|
For |
|
| 12. |
|
To reduce the notice period
for general meetings (Special Resolution) |
|
Management |
|
For |
|
For |
|
| 13. |
|
To adopt new Articles of
Association (Special Resolution) |
|
Management |
|
For |
|
For |
|
AVANTOR, INC.
| Security |
05352A100 |
Meeting Type |
Annual |
| Ticker Symbol |
AVTR |
Meeting Date |
11-May-2023 |
| Record Date |
17-Mar-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a. |
|
Election of Director: Juan
Andres |
|
Management |
|
For |
|
For |
|
| 1b. |
|
Election of Director: John
Carethers |
|
Management |
|
For |
|
For |
|
| 1c. |
|
Election of Director: Lan
Kang |
|
Management |
|
For |
|
For |
|
| 1d. |
|
Election of Director: Joseph
Massaro |
|
Management |
|
For |
|
For |
|
| 1e. |
|
Election of Director: Mala
Murthy |
|
Management |
|
For |
|
For |
|
| 1f. |
|
Election of Director: Jonathan
Peacock |
|
Management |
|
For |
|
For |
|
| 1g. |
|
Election of Director: Michael
Severino |
|
Management |
|
For |
|
For |
|
| 1h. |
|
Election of Director: Christi
Shaw |
|
Management |
|
For |
|
For |
|
| 1i. |
|
Election of Director: Michael
Stubblefield |
|
Management |
|
For |
|
For |
|
| 1j. |
|
Election of Director: Gregory
Summe |
|
Management |
|
For |
|
For |
|
| 2. |
|
Ratification of the Appointment
of Deloitte & Touche LLP as the Company's independent registered accounting firm for 2023. |
|
Management |
|
For |
|
For |
|
| 3. |
|
Approve, on an Advisory
Basis, Named Executive Officer Compensation. |
|
Management |
|
For |
|
For |
|
BIOGEN INC.
| Security |
09062X103 |
Meeting Type |
Annual |
| Ticker Symbol |
BIIB |
Meeting Date |
26-Jun-2023 |
| Record Date |
20-Apr-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a. |
|
Election of Director to
serve for a one-year term extending until the 2024 Annual Meeting: Not Applicable |
|
Management |
|
For |
|
For |
|
| 1b. |
|
Election of Director to
serve for a one-year term extending until the 2024 Annual Meeting: Caroline D. Dorsa |
|
Management |
|
For |
|
For |
|
| 1c. |
|
Election of Director to
serve for a one-year term extending until the 2024 Annual Meeting: Maria C. Freire |
|
Management |
|
For |
|
For |
|
| 1d. |
|
Election of Director to
serve for a one-year term extending until the 2024 Annual Meeting: William A. Hawkins |
|
Management |
|
For |
|
For |
|
| 1e. |
|
Election of Director to
serve for a one-year term extending until the 2024 Annual Meeting: Not Applicable |
|
Management |
|
For |
|
For |
|
| 1f. |
|
Election of Director to
serve for a one-year term extending until the 2024 Annual Meeting: Jesus B. Mantas |
|
Management |
|
For |
|
For |
|
| 1g. |
|
Election of Director to
serve for a one-year term extending until the 2024 Annual Meeting: Not Applicable |
|
Management |
|
For |
|
For |
|
| 1h. |
|
Election of Director to
serve for a one-year term extending until the 2024 Annual Meeting: Eric K. Rowinsky |
|
Management |
|
For |
|
For |
|
| 1i. |
|
Election of Director to
serve for a one-year term extending until the 2024 Annual Meeting: Stephen A. Sherwin |
|
Management |
|
For |
|
For |
|
| 1j. |
|
Election of Director to
serve for a one-year term extending until the 2024 Annual Meeting: Christopher A. Viehbacher |
|
Management |
|
For |
|
For |
|
| 2. |
|
To ratify the selection
of PricewaterhouseCoopers LLP as Biogen Inc.'s independent registered public accounting firm for the fiscal year ending December
31, 2023. |
|
Management |
|
For |
|
For |
|
| 3. |
|
Say on Pay - To approve
an advisory vote on executive compensation. |
|
Management |
|
For |
|
For |
|
| 4. |
|
Say When on Pay - To approve
an advisory vote on the frequency of the advisory vote on executive compensation. |
|
Management |
|
1 Year |
|
For |
|
| 5. |
|
To elect Susan Langer as
a director |
|
Management |
|
|
|
|
|
BOSTON SCIENTIFIC CORPORATION
| Security |
101137107 |
Meeting Type |
Annual |
| Ticker Symbol |
BSX |
Meeting Date |
04-May-2023 |
| Record Date |
10-Mar-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a. |
|
Election of Director: Nelda
J. Connors |
|
Management |
|
For |
|
For |
|
| 1b. |
|
Election of Director: Charles
J. Dockendorff |
|
Management |
|
For |
|
For |
|
| 1c. |
|
Election of Director: Yoshiaki
Fujimori |
|
Management |
|
For |
|
For |
|
| 1d. |
|
Election of Director: Edward
J. Ludwig |
|
Management |
|
For |
|
For |
|
| 1e. |
|
Election of Director: Michael
F. Mahoney |
|
Management |
|
For |
|
For |
|
| 1f. |
|
Election of Director: David
J. Roux |
|
Management |
|
For |
|
For |
|
| 1g. |
|
Election of Director: John
E. Sununu |
|
Management |
|
For |
|
For |
|
| 1h. |
|
Election of Director: David
S. Wichmann |
|
Management |
|
For |
|
For |
|
| 1i. |
|
Election of Director: Ellen
M. Zane |
|
Management |
|
For |
|
For |
|
| 2. |
|
To approve, on a non-binding,
advisory basis, the compensation of our named executive officers. |
|
Management |
|
For |
|
For |
|
| 3. |
|
To approve, on a non-binding,
advisory basis, the frequency of future advisory votes on the compensation of our named executive officers. |
|
Management |
|
1 Year |
|
For |
|
| 4. |
|
To ratify the appointment
of Ernst & Young LLP as our independent registered public accounting firm for the 2023 fiscal year. |
|
Management |
|
For |
|
For |
|
BRISTOL-MYERS SQUIBB COMPANY
| Security |
110122108 |
Meeting Type |
Annual |
| Ticker Symbol |
BMY |
Meeting Date |
02-May-2023 |
| Record Date |
13-Mar-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1A. |
|
Election of Director: Peter
J. Arduini |
|
Management |
|
For |
|
For |
|
| 1B. |
|
Election of Director: Deepak
L. Bhatt, M.D., M.P.H. |
|
Management |
|
For |
|
For |
|
| 1C. |
|
Election of Director: Giovanni
Caforio, M.D. |
|
Management |
|
For |
|
For |
|
| 1D. |
|
Election of Director: Julia
A. Haller, M.D. |
|
Management |
|
For |
|
For |
|
| 1E. |
|
Election of Director: Manuel
Hidalgo Medina, M.D., Ph.D. |
|
Management |
|
For |
|
For |
|
| 1F. |
|
Election of Director: Paula
A. Price |
|
Management |
|
For |
|
For |
|
| 1G. |
|
Election of Director: Derica
W. Rice |
|
Management |
|
For |
|
For |
|
| 1H. |
|
Election of Director: Theodore
R. Samuels |
|
Management |
|
For |
|
For |
|
| 1I. |
|
Election of Director: Gerald
L. Storch |
|
Management |
|
For |
|
For |
|
| 1J. |
|
Election of Director: Karen
H. Vousden, Ph.D. |
|
Management |
|
For |
|
For |
|
| 1K. |
|
Election of Director: Phyllis
R. Yale |
|
Management |
|
For |
|
For |
|
| 2. |
|
Advisory Vote to Approve
the Compensation of our Named Executive Officers. |
|
Management |
|
For |
|
For |
|
| 3. |
|
Advisory Vote on the Frequency
of the Advisory Vote on the Compensation of our Named Executive Officers. |
|
Management |
|
1 Year |
|
For |
|
| 4. |
|
Ratification of the Appointment
of an Independent Registered Public Accounting Firm. |
|
Management |
|
For |
|
For |
|
| 5. |
|
Shareholder Proposal on
the Adoption of a Board Policy that the Chairperson of the Board be an Independent Director. |
|
Shareholder |
|
For |
|
Against |
|
| 6. |
|
Shareholder Proposal on
Workplace Non-Discrimination Audit. |
|
Shareholder |
|
Against |
|
For |
|
| 7. |
|
Shareholder Proposal on
Special Shareholder Meeting Improvement. |
|
Shareholder |
|
Against |
|
For |
|
CHARLES RIVER LABORATORIES INTL., INC.
| Security |
159864107 |
Meeting Type |
Annual |
| Ticker Symbol |
CRL |
Meeting Date |
09-May-2023 |
| Record Date |
16-Mar-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a. |
|
Election of Director: James
C. Foster |
|
Management |
|
For |
|
For |
|
| 1b. |
|
Election of Director: Nancy
C. Andrews |
|
Management |
|
For |
|
For |
|
| 1c. |
|
Election of Director: Robert
Bertolini |
|
Management |
|
For |
|
For |
|
| 1d. |
|
Election of Director: Deborah
T. Kochevar |
|
Management |
|
For |
|
For |
|
| 1e. |
|
Election of Director: George
Llado, Sr. |
|
Management |
|
For |
|
For |
|
| 1f. |
|
Election of Director: Martin
W. Mackay |
|
Management |
|
For |
|
For |
|
| 1g. |
|
Election of Director: George
E. Massaro |
|
Management |
|
For |
|
For |
|
| 1h. |
|
Election of Director: C.
Richard Reese |
|
Management |
|
For |
|
For |
|
| 1i. |
|
Election of Director: Craig
B. Thompson |
|
Management |
|
For |
|
For |
|
| 1j. |
|
Election of Director: Richard
F. Wallman |
|
Management |
|
For |
|
For |
|
| 1k. |
|
Election of Director: Virginia
M. Wilson |
|
Management |
|
For |
|
For |
|
| 2. |
|
Advisory Approval of 2022
Executive Officer Compensation |
|
Management |
|
For |
|
For |
|
| 3. |
|
Advisory Vote on the Frequency
of Future Advisory Votes on Executive Compensation |
|
Management |
|
1 Year |
|
For |
|
| 4. |
|
Ratification of PricewaterhouseCoopers
LLC as independent registered public accounting firm for 2023 |
|
Management |
|
For |
|
For |
|
| 5. |
|
Proposal to publish a report
on non-human primates imported by Charles River Laboratories International, Inc. |
|
Management |
|
Against |
|
For |
|
COMMUNITY HEALTH SYSTEMS, INC.
| Security |
203668108 |
Meeting Type |
Annual |
| Ticker Symbol |
CYH |
Meeting Date |
09-May-2023 |
| Record Date |
13-Mar-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a. |
|
Election of Director: Susan
W. Brooks |
|
Management |
|
For |
|
For |
|
| 1b. |
|
Election of Director: John
A. Clerico |
|
Management |
|
For |
|
For |
|
| 1c. |
|
Election of Director: Michael
Dinkins |
|
Management |
|
For |
|
For |
|
| 1d. |
|
Election of Director: James
S. Ely III |
|
Management |
|
For |
|
For |
|
| 1e. |
|
Election of Director: John
A. Fry |
|
Management |
|
For |
|
For |
|
| 1f. |
|
Election of Director: Joseph
A. Hastings, D.M.D. |
|
Management |
|
For |
|
For |
|
| 1g. |
|
Election of Director: Tim
L. Hingtgen |
|
Management |
|
For |
|
For |
|
| 1h. |
|
Election of Director: Elizabeth
T. Hirsch |
|
Management |
|
For |
|
For |
|
| 1i. |
|
Election of Director: William
Norris Jennings, M.D. |
|
Management |
|
For |
|
For |
|
| 1j. |
|
Election of Director: K.
Ranga Krishnan, MBBS |
|
Management |
|
For |
|
For |
|
| 1k. |
|
Election of Director: Wayne
T. Smith |
|
Management |
|
For |
|
For |
|
| 1l. |
|
Election of Director: H.
James Williams, Ph.D. |
|
Management |
|
For |
|
For |
|
| 2. |
|
Proposal to approve on
an advisory (non-binding) basis the compensation of the Company's named executive officers. |
|
Management |
|
For |
|
For |
|
| 3. |
|
Proposal to approve on
an advisory (non-binding) basis the frequency of future advisory votes on the compensation of the Company's named executive officers. |
|
Management |
|
1 Year |
|
For |
|
| 4. |
|
Proposal to approve the
amendment and restatement of the Community Health Systems, Inc. 2009 Stock Option and Award Plan, which was approved by the Board
of Directors on March 22, 2023, subject to stockholder approval. |
|
Management |
|
For |
|
For |
|
| 5. |
|
Proposal to ratify the
selection of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending
December 31, 2023. |
|
Management |
|
For |
|
For |
|
CVS HEALTH CORPORATION
| Security |
126650100 |
Meeting Type |
Annual |
| Ticker Symbol |
CVS |
Meeting Date |
18-May-2023 |
| Record Date |
20-Mar-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a. |
|
Election of Director: Fernando
Aguirre |
|
Management |
|
For |
|
For |
|
| 1b. |
|
Election of Director: Jeffrey
R. Balser, M.D., Ph.D. |
|
Management |
|
For |
|
For |
|
| 1c. |
|
Election of Director: C.
David Brown II |
|
Management |
|
For |
|
For |
|
| 1d. |
|
Election of Director: Alecia
A. DeCoudreaux |
|
Management |
|
For |
|
For |
|
| 1e. |
|
Election of Director: Nancy-Ann
M. DeParle |
|
Management |
|
For |
|
For |
|
| 1f. |
|
Election of Director: Roger
N. Farah |
|
Management |
|
For |
|
For |
|
| 1g. |
|
Election of Director: Anne
M. Finucane |
|
Management |
|
For |
|
For |
|
| 1h. |
|
Election of Director: Edward
J. Ludwig |
|
Management |
|
For |
|
For |
|
| 1i. |
|
Election of Director: Karen
S. Lynch |
|
Management |
|
For |
|
For |
|
| 1j. |
|
Election of Director: Jean-Pierre
Millon |
|
Management |
|
For |
|
For |
|
| 1k. |
|
Election of Director: Mary
L. Schapiro |
|
Management |
|
For |
|
For |
|
| 2. |
|
Ratification of the Appointment
of Our Independent Registered Public Accounting Firm for 2023 |
|
Management |
|
For |
|
For |
|
| 3. |
|
Say on Pay, a Proposal
to Approve, on an Advisory Basis, the Company's Executive Compensation |
|
Management |
|
For |
|
For |
|
| 4. |
|
Proposal to Recommend,
on an Advisory Basis, the Frequency of Advisory Votes on Executive Compensation Votes |
|
Management |
|
1 Year |
|
For |
|
| 5. |
|
Stockholder Proposal Requesting
Paid Sick Leave for All Employees |
|
Shareholder |
|
Against |
|
For |
|
| 6. |
|
Stockholder Proposal for
Reducing our Ownership Threshold to Request a Special Stockholder Meeting |
|
Shareholder |
|
Against |
|
For |
|
| 7. |
|
Stockholder Proposal Regarding
"Fair Elections" and Requiring Stockholder Approval of Certain Types of By-law Amendments |
|
Shareholder |
|
Against |
|
For |
|
| 8. |
|
Stockholder Proposal Requesting
a Report on a "Worker Rights Assessment" |
|
Shareholder |
|
Against |
|
For |
|
| 9. |
|
Stockholder Proposal to
Prevent Company Directors from Simultaneously Sitting on the Boards of Directors of Any Other Company |
|
Shareholder |
|
Against |
|
For |
|
DANAHER CORPORATION
| Security |
235851102 |
Meeting Type |
Annual |
| Ticker Symbol |
DHR |
Meeting Date |
09-May-2023 |
| Record Date |
10-Mar-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a. |
|
Election of Director to
hold office until the 2024 Annual Meeting of Shareholders: Rainer M. Blair |
|
Management |
|
For |
|
For |
|
| 1b. |
|
Election of Director to
hold office until the 2024 Annual Meeting of Shareholders: Feroz Dewan |
|
Management |
|
For |
|
For |
|
| 1c. |
|
Election of Director to
hold office until the 2024 Annual Meeting of Shareholders: Linda Filler |
|
Management |
|
For |
|
For |
|
| 1d. |
|
Election of Director to
hold office until the 2024 Annual Meeting of Shareholders: Teri List |
|
Management |
|
For |
|
For |
|
| 1e. |
|
Election of Director to
hold office until the 2024 Annual Meeting of Shareholders: Walter G. Lohr, Jr. |
|
Management |
|
For |
|
For |
|
| 1f. |
|
Election of Director to
hold office until the 2024 Annual Meeting of Shareholders: Jessica L. Mega, MD, MPH |
|
Management |
|
For |
|
For |
|
| 1g. |
|
Election of Director to
hold office until the 2024 Annual Meeting of Shareholders: Mitchell P. Rales |
|
Management |
|
For |
|
For |
|
| 1h. |
|
Election of Director to
hold office until the 2024 Annual Meeting of Shareholders: Steven M. Rales |
|
Management |
|
For |
|
For |
|
| 1i. |
|
Election of Director to
hold office until the 2024 Annual Meeting of Shareholders: Pardis C. Sabeti, MD, D. PHIL |
|
Management |
|
For |
|
For |
|
| 1j. |
|
Election of Director to
hold office until the 2024 Annual Meeting of Shareholders: A. Shane Sanders |
|
Management |
|
For |
|
For |
|
| 1k. |
|
Election of Director to
hold office until the 2024 Annual Meeting of Shareholders: John T. Schwieters |
|
Management |
|
For |
|
For |
|
| 1l. |
|
Election of Director to
hold office until the 2024 Annual Meeting of Shareholders: Alan G. Spoon |
|
Management |
|
For |
|
For |
|
| 1m. |
|
Election of Director to
hold office until the 2024 Annual Meeting of Shareholders: Raymond C. Stevens, Ph.D |
|
Management |
|
For |
|
For |
|
| 1n. |
|
Election of Director to
hold office until the 2024 Annual Meeting of Shareholders: Elias A. Zerhouni, MD |
|
Management |
|
For |
|
For |
|
| 2. |
|
To ratify the selection
of Ernst & Young LLP as Danaher's independent registered public accounting firm for the year ending December 31, 2023. |
|
Management |
|
For |
|
For |
|
| 3. |
|
To approve on an advisory
basis the Company's named executive officer compensation. |
|
Management |
|
For |
|
For |
|
| 4. |
|
To hold an advisory vote
relating to the frequency of future shareholder advisory votes on the Company's executive officer compensation. |
|
Management |
|
1 Year |
|
For |
|
| 5. |
|
To act upon a shareholder
proposal requesting adoption of a policy separating the chair and CEO roles and requiring an independent Board Chair whenever possible. |
|
Shareholder |
|
For |
|
Against |
|
| 6. |
|
To act upon a shareholder
proposal requesting a report to shareholders on the effectiveness of the Company's diversity, equity and inclusion efforts. |
|
Shareholder |
|
Against |
|
For |
|
DEXCOM, INC.
| Security |
252131107 |
Meeting Type |
Annual |
| Ticker Symbol |
DXCM |
Meeting Date |
18-May-2023 |
| Record Date |
29-Mar-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1.1 |
|
Election of Director to
hold office until our 2024 Annual Meeting: Steven R. Altman |
|
Management |
|
For |
|
For |
|
| 1.2 |
|
Election of Director to
hold office until our 2024 Annual Meeting: Richard A. Collins |
|
Management |
|
For |
|
For |
|
| 1.3 |
|
Election of Director to
hold office until our 2024 Annual Meeting: Karen Dahut |
|
Management |
|
For |
|
For |
|
| 1.4 |
|
Election of Director to
hold office until our 2024 Annual Meeting: Mark G. Foletta |
|
Management |
|
For |
|
For |
|
| 1.5 |
|
Election of Director to
hold office until our 2024 Annual Meeting: Barbara E. Kahn |
|
Management |
|
For |
|
For |
|
| 1.6 |
|
Election of Director to
hold office until our 2024 Annual Meeting: Kyle Malady |
|
Management |
|
For |
|
For |
|
| 1.7 |
|
Election of Director to
hold office until our 2024 Annual Meeting: Eric J. Topol, M.D. |
|
Management |
|
For |
|
For |
|
| 2. |
|
To ratify the selection
by the Audit Committee of our Board of Directors of Ernst & Young LLP as our independent registered public accounting firm for
the fiscal year ending December 31, 2023. |
|
Management |
|
For |
|
For |
|
| 3. |
|
To hold a non-binding vote
on an advisory resolution to approve executive compensation. |
|
Management |
|
For |
|
For |
|
| 4. |
|
To recommend a non-binding
advisory resolution on the frequency of stockholder votes on executive compensation. |
|
Management |
|
1 Year |
|
For |
|
| 5. |
|
To hold a non-binding vote
on pay equity disclosure. |
|
Management |
|
Against |
|
For |
|
DIVERSIFIED HEALTHCARE TRUST
| Security |
25525P107 |
Meeting Type |
Annual |
| Ticker Symbol |
DHC |
Meeting Date |
05-Jun-2023 |
| Record Date |
17-Apr-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a. |
|
Election of Independent
Trustee: John L. Harrington |
|
Management |
|
For |
|
For |
|
| 1b. |
|
Election of Independent
Trustee: Lisa Harris Jones |
|
Management |
|
For |
|
For |
|
| 1c. |
|
Election of Independent
Trustee: Daniel F. LePage |
|
Management |
|
For |
|
For |
|
| 1d. |
|
Election of Independent
Trustee: David A. Pierce |
|
Management |
|
For |
|
For |
|
| 1e. |
|
Election of Independent
Trustee: Jeffrey P. Somers |
|
Management |
|
For |
|
For |
|
| 1f. |
|
Election of Managing Trustee:
Jennifer F. Francis |
|
Management |
|
For |
|
For |
|
| 1g. |
|
Election of Managing Trustee:
Adam D. Portnoy |
|
Management |
|
For |
|
For |
|
| 2. |
|
Advisory vote to approve
executive compensation. |
|
Management |
|
For |
|
For |
|
| 3. |
|
Advisory vote on the frequency
of future advisory votes to approve executive compensation. |
|
Management |
|
1 Year |
|
For |
|
| 4. |
|
Ratification of the appointment
of Deloitte & Touche LLP as independent auditors to serve for the 2023 fiscal year. |
|
Management |
|
For |
|
For |
|
EDWARDS LIFESCIENCES CORPORATION
| Security |
28176E108 |
Meeting Type |
Annual |
| Ticker Symbol |
EW |
Meeting Date |
11-May-2023 |
| Record Date |
13-Mar-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1.1 |
|
Election of Director: Kieran
T. Gallahue |
|
Management |
|
For |
|
For |
|
| 1.2 |
|
Election of Director: Leslie
S. Heisz |
|
Management |
|
For |
|
For |
|
| 1.3 |
|
Election of Director: Paul
A. LaViolette |
|
Management |
|
For |
|
For |
|
| 1.4 |
|
Election of Director: Steven
R. Loranger |
|
Management |
|
For |
|
For |
|
| 1.5 |
|
Election of Director: Martha
H. Marsh |
|
Management |
|
For |
|
For |
|
| 1.6 |
|
Election of Director: Michael
A. Mussallem |
|
Management |
|
For |
|
For |
|
| 1.7 |
|
Election of Director: Ramona
Sequeira |
|
Management |
|
For |
|
For |
|
| 1.8 |
|
Election of Director: Nicholas
J. Valeriani |
|
Management |
|
For |
|
For |
|
| 1.9 |
|
Election of Director: Bernard
J. Zovighian |
|
Management |
|
For |
|
For |
|
| 2. |
|
Advisory Vote to Approve
Named Executive Officer Compensation |
|
Management |
|
For |
|
For |
|
| 3. |
|
Advisory Vote to Approve
Frequency of Future Advisory Votes on Named Executive Officer Compensation |
|
Management |
|
1 Year |
|
For |
|
| 4. |
|
Ratification of Appointment
of Independent Registered Public Accounting Firm |
|
Management |
|
For |
|
For |
|
| 5. |
|
Approval of Amendment of
the Certificate of Incorporation to Provide for Exculpation of Officers |
|
Management |
|
For |
|
For |
|
| 6. |
|
Stockholder Proposal regarding
Independent Board Chairman Policy |
|
Shareholder |
|
Against |
|
For |
|
ELEVANCE HEALTH, INC.
| Security |
036752103 |
Meeting Type |
Annual |
| Ticker Symbol |
ELV |
Meeting Date |
10-May-2023 |
| Record Date |
17-Mar-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a. |
|
Election of Director: Gail
K. Boudreaux |
|
Management |
|
For |
|
For |
|
| 1b. |
|
Election of Director: R.
Kerry Clark |
|
Management |
|
For |
|
For |
|
| 1c. |
|
Election of Director: Robert
L. Dixon, Jr. |
|
Management |
|
For |
|
For |
|
| 1d. |
|
Election of Director: Deanna
D. Strable |
|
Management |
|
For |
|
For |
|
| 2. |
|
Advisory vote to approve
the compensation of our named executive officers. |
|
Management |
|
For |
|
For |
|
| 3. |
|
Advisory vote on the frequency
of the advisory vote to approve the compensation of our named executive officers. |
|
Management |
|
1 Year |
|
For |
|
| 4. |
|
To ratify the appointment
of Ernst & Young LLP as the independent registered public accounting firm for 2023. |
|
Management |
|
For |
|
For |
|
| 5. |
|
Shareholder proposal to
allow shareholders owning 10% or more of our common stock to call a special meeting of shareholders. |
|
Shareholder |
|
Against |
|
For |
|
| 6. |
|
Shareholder proposal requesting
annual reporting from third parties seeking financial support. |
|
Shareholder |
|
Against |
|
For |
|
ELI LILLY AND COMPANY
| Security |
532457108 |
Meeting Type |
Annual |
| Ticker Symbol |
LLY |
Meeting Date |
01-May-2023 |
| Record Date |
21-Feb-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a. |
|
Election of Director to
serve a three-year term: William G. Kaelin, Jr. |
|
Management |
|
For |
|
For |
|
| 1b. |
|
Election of Director to
serve a three-year term: David A. Ricks |
|
Management |
|
For |
|
For |
|
| 1c. |
|
Election of Director to
serve a three-year term: Marschall S. Runge |
|
Management |
|
For |
|
For |
|
| 1d. |
|
Election of Director to
serve a three-year term: Karen Walker |
|
Management |
|
For |
|
For |
|
| 2. |
|
Approval, on an advisory
basis, of the compensation paid to the company's named executive officers. |
|
Management |
|
For |
|
For |
|
| 3. |
|
Advisory vote on frequency
of future advisory votes on named executive officer compensation. |
|
Management |
|
1 Year |
|
For |
|
| 4. |
|
Ratification of the appointment
of Ernst & Young LLP as the independent auditor for 2023. |
|
Management |
|
For |
|
For |
|
| 5. |
|
Approval of amendments
to the company's Articles of Incorporation to eliminate the classified board structure. |
|
Management |
|
For |
|
For |
|
| 6. |
|
Approval of amendments
to the company's Articles of Incorporation to eliminate supermajority voting provisions. |
|
Management |
|
For |
|
For |
|
| 7. |
|
Shareholder proposal to
publish an annual report disclosing lobbying activities. |
|
Shareholder |
|
Against |
|
For |
|
| 8. |
|
Shareholder proposal to
eliminate supermajority voting requirements. |
|
Shareholder |
|
Against |
|
For |
|
| 9. |
|
Shareholder proposal to
establish and report on a process by which the impact of extended patent exclusivities on product access would be considered in deciding
whether to apply for secondary and tertiary patents. |
|
Shareholder |
|
Against |
|
For |
|
| 10. |
|
Shareholder proposal to
report on risks of supporting abortion. |
|
Shareholder |
|
Against |
|
For |
|
| 11. |
|
Shareholder proposal to
disclose lobbying activities and alignment with public policy positions and statements. |
|
Shareholder |
|
Against |
|
For |
|
| 12. |
|
Shareholder proposal to
report on effectiveness of the company's diversity, equity, and inclusion efforts. |
|
Shareholder |
|
Against |
|
For |
|
| 13. |
|
Shareholder proposal to
adopt a policy to require certain third-party organizations to annually report expenditures for political activities before Lilly
contributes to an organization. |
|
Shareholder |
|
Against |
|
For |
|
FUSION PHARMACEUTICALS INC
| Security |
36118A100 |
Meeting Type |
Annual |
| Ticker Symbol |
FUSN |
Meeting Date |
14-Jun-2023 |
| Record Date |
18-Apr-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1.1 |
|
Election of Director to
serve until the next annual meeting: Donald Bergstrom, M.D., Ph.D. |
|
Management |
|
For |
|
For |
|
| 1.2 |
|
Election of Director to
serve until the next annual meeting: Pablo Cagnoni, M.D. |
|
Management |
|
For |
|
For |
|
| 1.3 |
|
Election of Director to
serve until the next annual meeting: Johan Christenson, M.D., Ph.D. |
|
Management |
|
For |
|
For |
|
| 1.4 |
|
Election of Director to
serve until the next annual meeting: Barbara Duncan |
|
Management |
|
For |
|
For |
|
| 1.5 |
|
Election of Director to
serve until the next annual meeting: Steve Gannon |
|
Management |
|
For |
|
For |
|
| 1.6 |
|
Election of Director to
serve until the next annual meeting: Chau Khuong |
|
Management |
|
For |
|
For |
|
| 1.7 |
|
Election of Director to
serve until the next annual meeting: Philina Lee, Ph.D. |
|
Management |
|
For |
|
For |
|
| 1.8 |
|
Election of Director to
serve until the next annual meeting: Heather Preston, M.D. |
|
Management |
|
For |
|
For |
|
| 1.9 |
|
Election of Director to
serve until the next annual meeting: John Valliant, Ph.D. |
|
Management |
|
For |
|
For |
|
| 2. |
|
To appoint PricewaterhouseCoopers
LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2023. |
|
Management |
|
For |
|
For |
|
GALERA THERAPEUTICS, INC.
| Security |
36338D108 |
Meeting Type |
Annual |
| Ticker Symbol |
GRTX |
Meeting Date |
14-Jun-2023 |
| Record Date |
21-Apr-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1. |
|
DIRECTOR |
|
Management |
|
|
|
|
|
| |
|
1 |
Michael Powell,
Ph.D. |
|
|
|
For |
|
For |
|
| |
|
2 |
Linda West |
|
|
|
For |
|
For |
|
| 2. |
|
To ratify the
appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2023. |
|
Management |
|
For |
|
For |
|
GILEAD SCIENCES, INC.
| Security |
375558103 |
Meeting Type |
Annual |
| Ticker Symbol |
GILD |
Meeting Date |
03-May-2023 |
| Record Date |
15-Mar-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a. |
|
Election of Director: Jacqueline
K. Barton, Ph.D. |
|
Management |
|
For |
|
For |
|
| 1b. |
|
Election of Director: Jeffrey
A. Bluestone, Ph.D. |
|
Management |
|
For |
|
For |
|
| 1c. |
|
Election of Director: Sandra
J. Horning, M.D. |
|
Management |
|
For |
|
For |
|
| 1d. |
|
Election of Director: Kelly
A. Kramer |
|
Management |
|
For |
|
For |
|
| 1e. |
|
Election of Director: Kevin
E. Lofton |
|
Management |
|
For |
|
For |
|
| 1f. |
|
Election of Director: Harish
Manwani |
|
Management |
|
For |
|
For |
|
| 1g. |
|
Election of Director: Daniel
P. O'Day |
|
Management |
|
For |
|
For |
|
| 1h. |
|
Election of Director: Javier
J. Rodriguez |
|
Management |
|
For |
|
For |
|
| 1i. |
|
Election of Director: Anthony
Welters |
|
Management |
|
For |
|
For |
|
| 2. |
|
To ratify the selection
of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2023. |
|
Management |
|
For |
|
For |
|
| 3. |
|
To approve, on an advisory
basis, the compensation of our Named Executive Officers as presented in the Proxy Statement. |
|
Management |
|
For |
|
For |
|
| 4. |
|
To approve, on an advisory
basis, the frequency of future advisory stockholder votes on executive compensation. |
|
Management |
|
1 Year |
|
For |
|
| 5. |
|
To approve an amendment
and restatement of the Gilead Sciences, Inc. Employee Stock Purchase Plan and the Gilead Sciences, Inc. International Employee Stock
Purchase Plan. |
|
Management |
|
For |
|
For |
|
| 6. |
|
To vote on a stockholder
proposal, if properly presented at the meeting, requesting the Board implement a process to nominate at least one more candidate
than the number of directors to be elected. |
|
Shareholder |
|
Against |
|
For |
|
| 7. |
|
To vote on a stockholder
proposal, if properly presented at the meeting, requesting the Board amend the company governing documents to give street name shares
and non-street name shares an equal right to call a special stockholder meeting. |
|
Shareholder |
|
Against |
|
For |
|
| 8. |
|
To vote on a stockholder
proposal, if properly presented at the meeting, requesting a report on a process by which the impact of extended patent exclusivities
on product access would be considered in deciding whether to apply for secondary and tertiary patents. |
|
Shareholder |
|
Against |
|
For |
|
GLOBAL MEDICAL REIT INC.
| Security |
37954A204 |
Meeting Type |
Annual |
| Ticker Symbol |
GMRE |
Meeting Date |
10-May-2023 |
| Record Date |
15-Mar-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1.1 |
|
Election of Director to
serve until next annual meeting: Jeffrey M. Busch |
|
Management |
|
For |
|
For |
|
| 1.2 |
|
Election of Director to
serve until next annual meeting: Matthew Cypher |
|
Management |
|
For |
|
For |
|
| 1.3 |
|
Election of Director to
serve until next annual meeting: Ronald Marston |
|
Management |
|
For |
|
For |
|
| 1.4 |
|
Election of Director to
serve until next annual meeting: Henry E. Cole |
|
Management |
|
For |
|
For |
|
| 1.5 |
|
Election of Director to
serve until next annual meeting: Zhang Huiqi |
|
Management |
|
For |
|
For |
|
| 1.6 |
|
Election of Director to
serve until next annual meeting: Paula R. Crowley |
|
Management |
|
For |
|
For |
|
| 1.7 |
|
Election of Director to
serve until next annual meeting: Lori Wittman |
|
Management |
|
For |
|
For |
|
| 2. |
|
Advisory vote to approve
the compensation of the Company's named executive officers as described in the accompanying Proxy Statement. |
|
Management |
|
For |
|
For |
|
| 3. |
|
To ratify the appointment
of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the year ending December 31, 2023. |
|
Management |
|
For |
|
For |
|
GUARDANT HEALTH, INC.
| Security |
40131M109 |
Meeting Type |
Annual |
| Ticker Symbol |
GH |
Meeting Date |
14-Jun-2023 |
| Record Date |
17-Apr-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a. |
|
Election of Class II Director:
Ian Clark |
|
Management |
|
For |
|
For |
|
| 1b. |
|
Election of Class II Director:
Meghan Joyce |
|
Management |
|
For |
|
For |
|
| 1c. |
|
Election of Class II Director:
Samir Kaul |
|
Management |
|
For |
|
For |
|
| 2. |
|
Ratification of the appointment
of Deloitte & Touche LLP as Guardant Health, Inc.'s independent registered public accounting firm for the year ending December
31, 2023. |
|
Management |
|
For |
|
For |
|
| 3. |
|
Non-binding advisory vote
to approve Guardant Health, Inc.'s named executive officer compensation. |
|
Management |
|
For |
|
For |
|
HCA HEALTHCARE, INC.
| Security |
40412C101 |
Meeting Type |
Annual |
| Ticker Symbol |
HCA |
Meeting Date |
19-Apr-2023 |
| Record Date |
24-Feb-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a. |
|
Election of Director: Thomas
F. Frist III |
|
Management |
|
For |
|
For |
|
| 1b. |
|
Election of Director: Samuel
N. Hazen |
|
Management |
|
For |
|
For |
|
| 1c. |
|
Election of Director: Meg
G. Crofton |
|
Management |
|
For |
|
For |
|
| 1d. |
|
Election of Director: Robert
J. Dennis |
|
Management |
|
For |
|
For |
|
| 1e. |
|
Election of Director: Nancy-Ann
DeParle |
|
Management |
|
For |
|
For |
|
| 1f. |
|
Election of Director: William
R. Frist |
|
Management |
|
For |
|
For |
|
| 1g. |
|
Election of Director: Hugh
F. Johnston |
|
Management |
|
For |
|
For |
|
| 1h. |
|
Election of Director: Michael
W. Michelson |
|
Management |
|
For |
|
For |
|
| 1i. |
|
Election of Director: Wayne
J. Riley, M.D. |
|
Management |
|
For |
|
For |
|
| 1j. |
|
Election of Director: Andrea
B. Smith |
|
Management |
|
For |
|
For |
|
| 2. |
|
To ratify the appointment
of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2023. |
|
Management |
|
For |
|
For |
|
| 3. |
|
To approve the HCA Healthcare,
Inc. 2023 Employee Stock Purchase Plan. |
|
Management |
|
For |
|
For |
|
| 4. |
|
Advisory vote to approve
named executive officer compensation. |
|
Management |
|
For |
|
For |
|
| 5. |
|
Stockholder proposal, if
properly presented at the meeting, regarding political spending disclosure. |
|
Shareholder |
|
Against |
|
For |
|
| 6. |
|
Stockholder proposal, if
properly presented at the meeting, regarding amendment to Patient Safety and Quality of Care Committee charter. |
|
Shareholder |
|
Against |
|
For |
|
HEALTHCARE REALTY TRUST INCORPORATED
| Security |
42226K105 |
Meeting Type |
Annual |
| Ticker Symbol |
HR |
Meeting Date |
05-Jun-2023 |
| Record Date |
14-Apr-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a. |
|
Election of Director: Todd
J. Meredith |
|
Management |
|
For |
|
For |
|
| 1b. |
|
Election of Director: John
V. Abbott |
|
Management |
|
For |
|
For |
|
| 1c. |
|
Election of Director: Nancy
H. Agee |
|
Management |
|
For |
|
For |
|
| 1d. |
|
Election of Director: W.
Bradley Blair II |
|
Management |
|
For |
|
For |
|
| 1e. |
|
Election of Director: Vicki
U. Booth |
|
Management |
|
For |
|
For |
|
| 1f. |
|
Election of Director: Edward
H. Braman |
|
Management |
|
For |
|
For |
|
| 1g. |
|
Election of Director: Ajay
Gupta |
|
Management |
|
For |
|
For |
|
| 1h. |
|
Election of Director: James
J. Kilroy |
|
Management |
|
For |
|
For |
|
| 1i. |
|
Election of Director: Jay
P. Leupp |
|
Management |
|
For |
|
For |
|
| 1j. |
|
Election of Director: Peter
F. Lyle |
|
Management |
|
For |
|
For |
|
| 1k. |
|
Election of Director: Constance
B. Moore |
|
Management |
|
For |
|
For |
|
| 1l. |
|
Election of Director: John
Knox Singleton |
|
Management |
|
For |
|
For |
|
| 1m. |
|
Election of Director: Christann
M. Vasquez |
|
Management |
|
For |
|
For |
|
| 2. |
|
To ratify the appointment
of BDO USA, LLP as the independent registered public accounting firm for the Company and its subsidiaries for the Company's 2023
fiscal year. |
|
Management |
|
For |
|
For |
|
| 3. |
|
To approve, on a non-binding
advisory basis, the following resolution: RESOLVED, that the stockholders of Healthcare Realty Trust Incorporated approve, on a non-binding advisory basis, the compensation of the Named Executive Officers as disclosed pursuant to Item 402 of Regulation S-K in the
Company's proxy statement for the 2023 Annual Meeting of Stockholders. |
|
Management |
|
For |
|
For |
|
| 4. |
|
To approve, on a non-binding
advisory basis, the frequency of a non-binding advisory vote on executive compensation. |
|
Management |
|
1 Year |
|
For |
|
HEALTHCARE TRUST OF AMERICA, INC.
| Security |
42225P501 |
Meeting Type |
Special |
| Ticker Symbol |
HTA |
Meeting Date |
15-Jul-2022 |
| Record Date |
10-Jun-2022 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1. |
|
Company Issuance Proposal.
To approve the issuance of shares of class A common stock, $0.01 par value per share ("Company Common Stock"), of Healthcare
Trust of America, Inc. (the "Company"), pursuant to the Agreement and Plan of Merger, dated as of February 28, 2022, by
and among the Company, Healthcare Trust of America Holdings, LP, Healthcare Realty Trust Incorporated, and HR Acquisition 2, LLC
(the "Merger"). |
|
Management |
|
For |
|
For |
|
| 2. |
|
Company Golden Parachute
Proposal. To approve, in a non-binding advisory vote, the "golden parachute" compensation that may become vested and payable
to the Company's named executive officers in connection with the Merger. |
|
Management |
|
For |
|
For |
|
| 3. |
|
Company Adjournment Proposal.
To approve one or more adjournments of the Company Special Meeting to another date, time, place, or format, if necessary or appropriate,
including to solicit additional proxies in favor of the proposal to approve the issuance of shares of Company Common Stock in connection
with the Merger. |
|
Management |
|
For |
|
For |
|
HEALTHPEAK PROPERTIES, INC
| Security |
42250P103 |
Meeting Type |
Annual |
| Ticker Symbol |
PEAK |
Meeting Date |
27-Apr-2023 |
| Record Date |
01-Mar-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a. |
|
Election of Director: Scott
M. Brinker |
|
Management |
|
For |
|
For |
|
| 1b. |
|
Election of Director: Brian
G. Cartwright |
|
Management |
|
For |
|
For |
|
| 1c. |
|
Election of Director: James
B. Connor |
|
Management |
|
For |
|
For |
|
| 1d. |
|
Election of Director: Christine
N. Garvey |
|
Management |
|
For |
|
For |
|
| 1e. |
|
Election of Director: R.
Kent Griffin, Jr. |
|
Management |
|
For |
|
For |
|
| 1f. |
|
Election of Director: David
B. Henry |
|
Management |
|
For |
|
For |
|
| 1g. |
|
Election of Director: Sara
G. Lewis |
|
Management |
|
For |
|
For |
|
| 1h. |
|
Election of Director: Katherine
M. Sandstrom |
|
Management |
|
For |
|
For |
|
| 2. |
|
Approval of 2022 executive
compensation on an advisory basis. |
|
Management |
|
For |
|
For |
|
| 3. |
|
Approval, on an advisory
basis, of the frequency of future advisory votes on executive compensation. |
|
Management |
|
1 Year |
|
For |
|
| 4. |
|
Approval of the Healthpeak
Properties, Inc. 2023 Performance Incentive Plan. |
|
Management |
|
For |
|
For |
|
| 5. |
|
Ratification of the appointment
of Deloitte & Touche LLP as Healthpeak Properties, Inc.'s independent registered public accounting firm for the year ending December
31, 2023. |
|
Management |
|
For |
|
For |
|
HORIZON THERAPEUTICS PLC
| Security |
G46188101 |
Meeting Type |
Special |
| Ticker Symbol |
HZNP |
Meeting Date |
24-Feb-2023 |
| Record Date |
19-Jan-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1. |
|
Ordinary Resolution to
approve the Scheme of Arrangement and authorize the directors of Horizon to take all such actions as they consider necessary or appropriate
for carrying the Scheme of Arrangement into effect. |
|
Management |
|
For |
|
For |
|
| 2. |
|
Special Resolution to amend
the articles of association of Horizon so that any Horizon Shares that are issued on or after the Voting Record Time to persons other
than Acquirer Sub or its nominee(s) will either be subject to the terms of the Scheme of Arrangement or be immediately and automatically
acquired by Acquirer Sub and/or its nominee(s) for the Scheme Consideration. |
|
Management |
|
For |
|
For |
|
| 3. |
|
Ordinary Resolution to
approve, on a non-binding, advisory basis, specified compensatory arrangements between Horizon and its named executive officers relating
to the Transaction. |
|
Management |
|
For |
|
For |
|
| 4. |
|
Ordinary Resolution to
approve any motion by the Chairman to adjourn the EGM or any adjournments thereof, to solicit additional proxies in favor of the
approval of the resolutions if there are insufficient votes at the time of the EGM to approve resolutions 1 and 2. |
|
Management |
|
For |
|
For |
|
HORIZON THERAPEUTICS PLC
| Security |
G46188111 |
Meeting Type |
Special |
| Ticker Symbol |
HZNP |
Meeting Date |
24-Feb-2023 |
| Record Date |
19-Jan-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1. |
|
That the Scheme of Arrangement
in its original form or with or subject to any modification(s), addition(s) or condition(s) approved or imposed by the Irish High
Court be agreed to. |
|
Management |
|
For |
|
For |
|
HUMANA INC.
| Security |
444859102 |
Meeting Type |
Annual |
| Ticker Symbol |
HUM |
Meeting Date |
20-Apr-2023 |
| Record Date |
28-Feb-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a) |
|
Election of Director: Raquel
C. Bono, M.D. |
|
Management |
|
For |
|
For |
|
| 1b) |
|
Election of Director: Bruce
D. Broussard |
|
Management |
|
For |
|
For |
|
| 1c) |
|
Election of Director: Frank
A. D'Amelio |
|
Management |
|
For |
|
For |
|
| 1d) |
|
Election of Director: David
T. Feinberg, M.D. |
|
Management |
|
For |
|
For |
|
| 1e) |
|
Election of Director: Wayne
A. I. Frederick, M.D. |
|
Management |
|
For |
|
For |
|
| 1f) |
|
Election of Director: John
W. Garratt |
|
Management |
|
For |
|
For |
|
| 1g) |
|
Election of Director: Kurt
J. Hilzinger |
|
Management |
|
For |
|
For |
|
| 1h) |
|
Election of Director: Karen
W. Katz |
|
Management |
|
For |
|
For |
|
| 1i) |
|
Election of Director: Marcy
S. Klevorn |
|
Management |
|
For |
|
For |
|
| 1j) |
|
Election of Director: William
J. McDonald |
|
Management |
|
For |
|
For |
|
| 1k) |
|
Election of Director: Jorge
S. Mesquita |
|
Management |
|
For |
|
For |
|
| 1l) |
|
Election of Director: Brad
D. Smith |
|
Management |
|
For |
|
For |
|
| 2. |
|
The ratification of the
appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm. |
|
Management |
|
For |
|
For |
|
| 3. |
|
Non-binding advisory vote
for the approval of the compensation of the named executive officers as disclosed in the 2023 proxy statement. |
|
Management |
|
For |
|
For |
|
| 4. |
|
Non-binding advisory vote
for the approval of the frequency with which future stockholder votes on the compensation of the named executive officers will be
held. |
|
Management |
|
1 Year |
|
For |
|
ICON PLC
| Security |
G4705A100 |
Meeting Type |
Annual |
| Ticker Symbol |
ICLR |
Meeting Date |
26-Jul-2022 |
| Record Date |
06-Jun-2022 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1.1 |
|
Election of Director: Dr.
Steve Cutler |
|
Management |
|
For |
|
For |
|
| 1.2 |
|
Election of Director: Dr.
John Climax |
|
Management |
|
For |
|
For |
|
| 1.3 |
|
Election of Director: Mr.
Ronan Murphy |
|
Management |
|
For |
|
For |
|
| 2. |
|
To review the Company's
affairs and consider the Accounts and Reports |
|
Management |
|
For |
|
For |
|
| 3. |
|
To authorise the fixing
of the Auditors' Remuneration |
|
Management |
|
For |
|
For |
|
| 4. |
|
To authorise the Company
to allot shares |
|
Management |
|
For |
|
For |
|
| 5. |
|
To disapply the statutory
pre-emption rights |
|
Management |
|
For |
|
For |
|
| 6. |
|
To disapply the statutory
pre-emption rights for funding capital investment or acquisitions |
|
Management |
|
For |
|
For |
|
| 7. |
|
To authorise the Company
to make market purchases of shares |
|
Management |
|
For |
|
For |
|
| 8. |
|
To authorise the price
range at which the Company can reissue shares that it holds as treasury shares |
|
Management |
|
For |
|
For |
|
IDEXX LABORATORIES, INC.
| Security |
45168D104 |
Meeting Type |
Annual |
| Ticker Symbol |
IDXX |
Meeting Date |
17-May-2023 |
| Record Date |
20-Mar-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a. |
|
Election of Director (Proposal
One): Daniel M. Junius |
|
Management |
|
For |
|
For |
|
| 1b. |
|
Election of Director (Proposal
One): Lawrence D. Kingsley |
|
Management |
|
For |
|
For |
|
| 1c. |
|
Election of Director (Proposal
One): Sophie V. Vandebroek, PhD |
|
Management |
|
For |
|
For |
|
| 2. |
|
Ratification of Appointment
of Independent Registered Public Accounting Firm. To ratify the selection of PricewaterhouseCoopers LLP as the Company's independent
registered public accounting firm for the current fiscal year (Proposal Two). |
|
Management |
|
For |
|
For |
|
| 3. |
|
Advisory Vote on Executive
Compensation. To approve a nonbinding advisory resolution on the Company's executive compensation (Proposal Three). |
|
Management |
|
For |
|
For |
|
| 4. |
|
Advisory Vote on the Frequency
of Advisory Votes on Executive Compensation. To recommend, by nonbinding advisory vote, the frequency of future advisory votes on
the Company's executive compensation (Proposal Four). |
|
Management |
|
1 Year |
|
For |
|
ILLUMINA, INC.
| Security |
452327109 |
Meeting Type |
Contested-Annual |
| Ticker Symbol |
ILMN |
Meeting Date |
25-May-2023 |
| Record Date |
03-Apr-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1A. |
|
Illumina Nominee: Frances
Arnold, Ph.D. |
|
Management |
|
For |
|
For |
|
| 1B. |
|
Illumina Nominee: Francis
A. deSouza |
|
Management |
|
Withheld |
|
For |
|
| 1C. |
|
Illumina Nominee: Caroline
D. Dorsa |
|
Management |
|
Withheld |
|
For |
|
| 1D. |
|
Illumina Nominee: Robert
S. Epstein, M.D. |
|
Management |
|
Withheld |
|
For |
|
| 1E. |
|
Illumina Nominee: Scott
Gottlieb, M.D. |
|
Management |
|
For |
|
For |
|
| 1F. |
|
Illumina Nominee: Gary
S. Guthart, Ph.D. |
|
Management |
|
Withheld |
|
For |
|
| 1G. |
|
Illumina Nominee: Philip
W. Schiller |
|
Management |
|
For |
|
For |
|
| 1H. |
|
Illumina Nominee: Susan
E. Siegel |
|
Management |
|
For |
|
For |
|
| 1I. |
|
Illumina Nominee: John
W. Thompson |
|
Management |
|
Withheld |
|
For |
|
| 1J. |
|
Icahn Group Nominee OPPOSED
by the Company: Vincent J. Intrieri |
|
Management |
|
For |
|
For |
|
| 1K. |
|
Icahn Group Nominee OPPOSED
by the Company: Jesse A. Lynn |
|
Management |
|
Withheld |
|
For |
|
| 1L. |
|
Icahn Group Nominee OPPOSED
by the Company: Andrew J. Teno |
|
Management |
|
Withheld |
|
For |
|
| 2. |
|
To ratify the appointment
of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2023. |
|
Management |
|
For |
|
For |
|
| 3. |
|
To approve, on an advisory
basis, the compensation provided to our named executive officers as disclosed in the Proxy Statement. |
|
Management |
|
Against |
|
Against |
|
| 4. |
|
To approve, on an advisory
basis, the frequency of holding an advisory vote to approve compensation provided to our "named executive officers". |
|
Management |
|
1 Year |
|
For |
|
| 5. |
|
To approve certain amendments
to the Illumina, Inc. 2015 Stock and Incentive Plan |
|
Management |
|
For |
|
For |
|
INTUITIVE SURGICAL, INC.
| Security |
46120E602 |
Meeting Type |
Annual |
| Ticker Symbol |
ISRG |
Meeting Date |
27-Apr-2023 |
| Record Date |
28-Feb-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a. |
|
Election of Director: Craig
H. Barratt, Ph.D. |
|
Management |
|
For |
|
For |
|
| 1b. |
|
Election of Director: Joseph
C. Beery |
|
Management |
|
For |
|
For |
|
| 1c. |
|
Election of Director: Gary
S. Guthart, Ph.D. |
|
Management |
|
For |
|
For |
|
| 1d. |
|
Election of Director: Amal
M. Johnson |
|
Management |
|
For |
|
For |
|
| 1e. |
|
Election of Director: Don
R. Kania, Ph.D. |
|
Management |
|
For |
|
For |
|
| 1f. |
|
Election of Director: Amy
L. Ladd, M.D. |
|
Management |
|
For |
|
For |
|
| 1g. |
|
Election of Director: Keith
R. Leonard, Jr. |
|
Management |
|
For |
|
For |
|
| 1h. |
|
Election of Director: Alan
J. Levy, Ph.D. |
|
Management |
|
For |
|
For |
|
| 1i. |
|
Election of Director: Jami
Dover Nachtsheim |
|
Management |
|
For |
|
For |
|
| 1j. |
|
Election of Director: Monica
P. Reed, M.D. |
|
Management |
|
For |
|
For |
|
| 1k. |
|
Election of Director: Mark
J. Rubash |
|
Management |
|
For |
|
For |
|
| 2. |
|
To approve, by advisory
vote, the compensation of the Company's Named Executive Officers |
|
Management |
|
For |
|
For |
|
| 3. |
|
To approve, by advisory
vote, the frequency of the advisory vote on the compensation of the Company's Named Executive Officers. |
|
Management |
|
1 Year |
|
For |
|
| 4. |
|
The ratification of appointment
of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December
31, 2023. |
|
Management |
|
For |
|
For |
|
| 5. |
|
The stockholder proposal
regarding pay equity disclosure. |
|
Shareholder |
|
Against |
|
For |
|
IO LIGHT HOLDINGS, INC
| Security |
N/A |
Meeting Type |
Written Consent |
| Ticker Symbol |
N/A |
Meeting Date |
27-Sep-2022 |
| Record Date |
N/A |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1. |
|
Approval of Subsidiary
Transfer Documents |
|
Management |
|
For |
|
For |
|
| 2. |
|
General Resolutions |
|
Management |
|
For |
|
For |
|
IO LIGHT HOLDINGS, INC
| Security |
N/A |
Meeting Type |
Written Consent |
| Ticker Symbol |
N/A |
Meeting Date |
30-Dec-2022 |
| Record Date |
N/A |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1. |
|
Approval of Series B Financing |
|
Management |
|
For |
|
For |
|
| 2. |
|
Approval of Amended and
Restated Certification of Incorporation |
|
Management |
|
For |
|
For |
|
| 3. |
|
Approval of Amended and
Restated Stockholders Agreement |
|
Management |
|
For |
|
For |
|
IQVIA HOLDINGS INC.
| Security |
46266C105 |
Meeting Type |
Annual |
| Ticker Symbol |
IQV |
Meeting Date |
18-Apr-2023 |
| Record Date |
17-Feb-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a. |
|
Election of Director: Carol
J. Burt |
|
Management |
|
For |
|
For |
|
| 1b. |
|
Election of Director: Colleen
A. Goggins |
|
Management |
|
For |
|
For |
|
| 1c. |
|
Election of Director: Sheila
A. Stamps |
|
Management |
|
For |
|
For |
|
| 2. |
|
Approve an advisory (non-binding)
resolution to approve IQVIA's executive compensation (say-on-pay). |
|
Management |
|
For |
|
For |
|
| 3. |
|
Approve a Company proposal
to amend IQVIA's Certificate of Incorporation to adopt a stockholders' right to request a special stockholders' meeting. |
|
Management |
|
For |
|
For |
|
| 4. |
|
If properly presented,
a stockholder proposal concerning special stockholder meetings. |
|
Shareholder |
|
For |
|
Against |
|
| 5. |
|
If properly presented,
a stockholder proposal for separate Chairman and Chief Executive Officer roles. |
|
Shareholder |
|
For |
|
Against |
|
| 6. |
|
Ratification of the appointment
of PricewaterhouseCoopers LLP as IQVIA's independent registered public accounting firm for 2023. |
|
Management |
|
For |
|
For |
|
JAZZ PHARMACEUTICALS PLC
| Security |
G50871105 |
Meeting Type |
Annual |
| Ticker Symbol |
JAZZ |
Meeting Date |
28-Jul-2022 |
| Record Date |
01-Jun-2022 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a. |
|
Election of Director to
hold office until the 2025 Annual General Meeting: Jennifer E. Cook |
|
Management |
|
For |
|
For |
|
| 1b. |
|
Election of Director to
hold office until the 2025 Annual General Meeting: Patrick G. Enright |
|
Management |
|
For |
|
For |
|
| 1c. |
|
Election of Director to
hold office until the 2025 Annual General Meeting: Seamus Mulligan |
|
Management |
|
For |
|
For |
|
| 1d. |
|
Election of Director to
hold office until the 2025 Annual General Meeting: Norbert G. Riedel, Ph.D. |
|
Management |
|
For |
|
For |
|
| 2. |
|
To ratify, on a non-binding
advisory basis, the appointment of KPMG as the independent auditors of Jazz Pharmaceuticals plc for the fiscal year ending December
31, 2022 and to authorize, in a binding vote, the Board of Directors, acting through the audit committee, to determine KPMG's remuneration. |
|
Management |
|
For |
|
For |
|
| 3. |
|
To approve, on a non-binding
advisory basis, the compensation of Jazz Pharmaceuticals plc's named executive officers as disclosed in the proxy statement. |
|
Management |
|
For |
|
For |
|
| 4. |
|
To grant the Board of Directors
authority under Irish law to allot and issue ordinary shares for cash without first offering those ordinary shares to existing shareholders
pursuant to the statutory pre-emption right that would otherwise apply. |
|
Management |
|
For |
|
For |
|
| 5. |
|
To approve any motion to
adjourn the Annual General Meeting, or any adjournments thereof, to another time and place to solicit additional proxies if there
are insufficient votes at the time of the Annual General Meeting to approve Proposal 4. |
|
Management |
|
For |
|
For |
|
JOHNSON & JOHNSON
| Security |
478160104 |
Meeting Type |
Annual |
| Ticker Symbol |
JNJ |
Meeting Date |
27-Apr-2023 |
| Record Date |
28-Feb-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a. |
|
Election of Director: Darius
Adamczyk |
|
Management |
|
For |
|
For |
|
| 1b. |
|
Election of Director: Mary
C. Beckerle |
|
Management |
|
For |
|
For |
|
| 1c. |
|
Election of Director: D.
Scott Davis |
|
Management |
|
For |
|
For |
|
| 1d. |
|
Election of Director: Jennifer
A. Doudna |
|
Management |
|
For |
|
For |
|
| 1e. |
|
Election of Director: Joaquin
Duato |
|
Management |
|
For |
|
For |
|
| 1f. |
|
Election of Director: Marillyn
A. Hewson |
|
Management |
|
For |
|
For |
|
| 1g. |
|
Election of Director: Paula
A. Johnson |
|
Management |
|
For |
|
For |
|
| 1h. |
|
Election of Director: Hubert
Joly |
|
Management |
|
For |
|
For |
|
| 1I. |
|
Election of Director: Mark
B. McClellan |
|
Management |
|
For |
|
For |
|
| 1j. |
|
Election of Director: Anne
M. Mulcahy |
|
Management |
|
For |
|
For |
|
| 1k. |
|
Election of Director: Mark
A. Weinberger |
|
Management |
|
For |
|
For |
|
| 1l. |
|
Election of Director: Nadja
Y. West |
|
Management |
|
For |
|
For |
|
| 2. |
|
Advisory Vote to Approve
Named Executive Officer Compensation |
|
Management |
|
For |
|
For |
|
| 3. |
|
Advisory Vote on the Frequency
of Voting to Approve Named Executive Officer Compensation |
|
Management |
|
1 Year |
|
For |
|
| 4. |
|
Ratification of Appointment
of PricewaterhouseCoopers LLP as the Independent Registered Public Accounting Firm |
|
Management |
|
For |
|
For |
|
| 5. |
|
Proposal Withdrawn
(Federal Securities Laws Mandatory Arbitration Bylaw) |
|
Shareholder |
|
Abstain |
|
|
|
| 6. |
|
Vaccine Pricing Report |
|
Shareholder |
|
Against |
|
For |
|
| 7. |
|
Executive Compensation
Adjustment Policy |
|
Shareholder |
|
Against |
|
For |
|
| 8. |
|
Impact of Extended Patent
Exclusivities on Product Access |
|
Shareholder |
|
Against |
|
For |
|
LABORATORY CORP. OF AMERICA HOLDINGS
| Security |
50540R409 |
Meeting Type |
Annual |
| Ticker Symbol |
LH |
Meeting Date |
11-May-2023 |
| Record Date |
16-Mar-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a. |
|
Election of Director: Kerrii
B. Anderson |
|
Management |
|
For |
|
For |
|
| 1b. |
|
Election of Director: Jean-Luc
Bélingard |
|
Management |
|
For |
|
For |
|
| 1c. |
|
Election of Director: Jeffrey
A. Davis |
|
Management |
|
For |
|
For |
|
| 1d. |
|
Election of Director: D.
Gary Gilliland, M.D., Ph.D. |
|
Management |
|
For |
|
For |
|
| 1e. |
|
Election of Director: Kirsten
M. Kliphouse |
|
Management |
|
For |
|
For |
|
| 1f. |
|
Election of Director: Garheng
Kong, M.D., Ph.D. |
|
Management |
|
For |
|
For |
|
| 1g. |
|
Election of Director: Peter
M. Neupert |
|
Management |
|
For |
|
For |
|
| 1h. |
|
Election of Director: Richelle
P. Parham |
|
Management |
|
For |
|
For |
|
| 1i. |
|
Election of Director: Adam
H. Schechter |
|
Management |
|
For |
|
For |
|
| 1j. |
|
Election of Director: Kathryn
E. Wengel |
|
Management |
|
For |
|
For |
|
| 1k. |
|
Election of Director: R.
Sanders Williams, M.D. |
|
Management |
|
For |
|
For |
|
| 2. |
|
To approve, by non-binding
vote, executive compensation. |
|
Management |
|
For |
|
For |
|
| 3. |
|
To recommend by non-binding
vote, the frequency of future non-binding votes on executive compensation. |
|
Management |
|
1 Year |
|
For |
|
| 4. |
|
Ratification of the appointment
of Deloitte and Touche LLP as Laboratory Corporation of America Holdings' independent registered public accounting firm for the year
ending December 31, 2023. |
|
Management |
|
For |
|
For |
|
| 5. |
|
Shareholder proposal relating
to a policy regarding separation of the roles of Board Chairman and Chief Executive Officer. |
|
Shareholder |
|
For |
|
Against |
|
| 6. |
|
Shareholder proposal regarding
a Board report on transport of nonhuman primates within the U.S. |
|
Shareholder |
|
Against |
|
For |
|
| 7. |
|
Shareholder proposal regarding
a Board report on known risks of fulfilling information requests and mitigation strategies. |
|
Shareholder |
|
Against |
|
For |
|
LANTHEUS HOLDINGS, INC.
| Security |
516544103 |
Meeting Type |
Annual |
| Ticker Symbol |
LNTH |
Meeting Date |
27-Apr-2023 |
| Record Date |
06-Mar-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1.1 |
|
Election of Class II Director:
Ms. Minnie Baylor-Henry |
|
Management |
|
For |
|
For |
|
| 1.2 |
|
Election of Class II Director:
Mr. Heinz Mäusli |
|
Management |
|
For |
|
For |
|
| 1.3 |
|
Election of Class II Director:
Ms. Julie McHugh |
|
Management |
|
For |
|
For |
|
| 2. |
|
The approval, on an advisory
basis, of the compensation paid to our named executive officers. |
|
Management |
|
For |
|
For |
|
| 3. |
|
The approval of the Lantheus
Holdings, Inc. 2023 Employee Stock Purchase Plan. |
|
Management |
|
For |
|
For |
|
| 4. |
|
The ratification of the
appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December
31, 2023. |
|
Management |
|
For |
|
For |
|
LIVANOVA PLC
| Security |
G5509L101 |
Meeting Type |
Annual |
| Ticker Symbol |
LIVN |
Meeting Date |
12-Jun-2023 |
| Record Date |
21-Apr-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a. |
|
Election of Director: Francesco
Bianchi |
|
Management |
|
For |
|
For |
|
| 1b. |
|
Election of Director: Stacy
Enxing Seng |
|
Management |
|
For |
|
For |
|
| 1c. |
|
Election of Director: William
Kozy |
|
Management |
|
For |
|
For |
|
| 1d. |
|
Election of Director: Daniel
Moore |
|
Management |
|
For |
|
For |
|
| 1e. |
|
Election of Director: Dr.
Sharon O'Kane |
|
Management |
|
For |
|
For |
|
| 1f. |
|
Election of Director: Andrea
Saia |
|
Management |
|
For |
|
For |
|
| 1g. |
|
Election of Director: Todd
Schermerhorn |
|
Management |
|
For |
|
For |
|
| 1h. |
|
Election of Director: Brooke
Story |
|
Management |
|
For |
|
For |
|
| 1i. |
|
Election of Director: Peter
Wilver |
|
Management |
|
For |
|
For |
|
| 2. |
|
Ordinary Resolution: To
approve, on an advisory basis, the Company's compensation of its named executive officers ("US Say-on-Pay"). |
|
Management |
|
For |
|
For |
|
| 3. |
|
Ordinary Resolution: To
ratify the appointment of PricewaterhouseCoopers LLP, a Delaware limited liability partnership ("PwC-US"), as the Company's
independent registered public accounting firm for 2023. |
|
Management |
|
For |
|
For |
|
| 4. |
|
Ordinary Resolution: To
approve the Amended and Restated LivaNova PLC 2022 Incentive Award Plan. |
|
Management |
|
For |
|
For |
|
| 5. |
|
Ordinary Resolution: To
generally and unconditionally authorize the directors, for the purposes of section 551 of the Companies Act 2006 (the "Companies
Act") to exercise all powers of the Company to allot shares in the Company and to grant rights to subscribe for, or to convert
any security into, shares in the Company up to an aggregate nominal amount of £10,770,848, provided that: (A) (unless previously
revoked, varied or renewed by the Company) this authority will expire at the end ...(due to space limits, see proxy material for
full proposal). |
|
Management |
|
For |
|
For |
|
| 6. |
|
Special Resolution: Subject
to the passing of resolution 5 and in accordance with sections 570 and 573 of the Companies Act, to empower the directors generally
to allot equity securities (as defined in section 560 of the Companies Act) for cash pursuant to the authority conferred by resolution
5, and/or to sell Ordinary Shares (as defined in section 560 of the Companies Act) held by the Company as treasury shares for cash,
in each case as if section 561 of the Companies Act (existing shareholders' ...(due to space limits, see proxy material for full
proposal). |
|
Management |
|
For |
|
For |
|
| 7. |
|
Ordinary Resolution: To
approve, on an advisory basis, the United Kingdom ("UK") directors' remuneration report in the form set out in the Company's
UK annual report (the "UK Annual Report") for the period ended December 31, 2022. |
|
Management |
|
For |
|
For |
|
| 8. |
|
Ordinary Resolution: To
receive and adopt the Company's audited UK statutory accounts for the year ended December 31, 2022, together with the reports of
the directors and auditors thereon. |
|
Management |
|
For |
|
For |
|
| 9. |
|
Ordinary Resolution: To
re-appoint PricewaterhouseCoopers LLP, a limited liability partnership organized under the laws of England ("PwC-UK"),
as the Company's UK statutory auditor for 2023. |
|
Management |
|
For |
|
For |
|
| 10. |
|
Ordinary Resolution: To
authorize the directors and/or the Audit and Compliance Committee to determine the remuneration of the Company's UK statutory auditor. |
|
Management |
|
For |
|
For |
|
LTC PROPERTIES, INC.
| Security |
502175102 |
Meeting Type |
Annual |
| Ticker Symbol |
LTC |
Meeting Date |
24-May-2023 |
| Record Date |
10-Apr-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a. |
|
Election of Director to
hold office until the 2024 Annual Meeting of Stockholders: Cornelia Cheng |
|
Management |
|
For |
|
For |
|
| 1b. |
|
Election of Director to
hold office until the 2024 Annual Meeting of Stockholders: Boyd W. Hendrickson |
|
Management |
|
For |
|
For |
|
| 1c. |
|
Election of Director to
hold office until the 2024 Annual Meeting of Stockholders: James J. Pieczynski |
|
Management |
|
For |
|
For |
|
| 1d. |
|
Election of Director to
hold office until the 2024 Annual Meeting of Stockholders: Devra G. Shapiro |
|
Management |
|
For |
|
For |
|
| 1e. |
|
Election of Director to
hold office until the 2024 Annual Meeting of Stockholders: Wendy L. Simpson |
|
Management |
|
For |
|
For |
|
| 1f. |
|
Election of Director to
hold office until the 2024 Annual Meeting of Stockholders: Timothy J. Triche |
|
Management |
|
For |
|
For |
|
| 2. |
|
Ratification of independent
registered public accounting firm. |
|
Management |
|
For |
|
For |
|
| 3. |
|
Advisory vote to approve
named executive officer compensation. |
|
Management |
|
For |
|
For |
|
| 4. |
|
Advisory vote on the frequency
of the advisory vote on executive compensation. |
|
Management |
|
1 Year |
|
For |
|
MCKESSON CORPORATION
| Security |
58155Q103 |
Meeting Type |
Annual |
| Ticker Symbol |
MCK |
Meeting Date |
22-Jul-2022 |
| Record Date |
27-May-2022 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a. |
|
Election of Director for
a one-year term: Richard H. Carmona, M.D. |
|
Management |
|
For |
|
For |
|
| 1b. |
|
Election of Director for
a one-year term: Dominic J. Caruso |
|
Management |
|
For |
|
For |
|
| 1c. |
|
Election of Director for
a one-year term: W. Roy Dunbar |
|
Management |
|
For |
|
For |
|
| 1d. |
|
Election of Director for
a one-year term: James H. Hinton |
|
Management |
|
For |
|
For |
|
| 1e. |
|
Election of Director for
a one-year term: Donald R. Knauss |
|
Management |
|
For |
|
For |
|
| 1f. |
|
Election of Director for
a one-year term: Bradley E. Lerman |
|
Management |
|
For |
|
For |
|
| 1g. |
|
Election of Director for
a one-year term: Linda P. Mantia |
|
Management |
|
For |
|
For |
|
| 1h. |
|
Election of Director for
a one-year term: Maria Martinez |
|
Management |
|
For |
|
For |
|
| 1i. |
|
Election of Director for
a one-year term: Susan R. Salka |
|
Management |
|
For |
|
For |
|
| 1j. |
|
Election of Director for
a one-year term: Brian S. Tyler |
|
Management |
|
For |
|
For |
|
| 1k. |
|
Election of Director for
a one-year term: Kathleen Wilson-Thompson |
|
Management |
|
For |
|
For |
|
| 2. |
|
Ratification of Appointment
of Deloitte & Touche LLP as the Company's Independent Registered Public Accounting Firm for Fiscal Year 2023. |
|
Management |
|
For |
|
For |
|
| 3. |
|
Advisory vote on executive
compensation. |
|
Management |
|
For |
|
For |
|
| 4. |
|
Approval of our 2022 Stock
Plan. |
|
Management |
|
For |
|
For |
|
| 5. |
|
Approval of Amendment to
our 2000 Employee Stock Purchase Plan. |
|
Management |
|
For |
|
For |
|
| 6. |
|
Shareholder Proposal on
Special Shareholder Meeting Improvement. |
|
Shareholder |
|
Against |
|
For |
|
| 7. |
|
Shareholder Proposal on
Transparency in Rule 10b5-1 Trading Policy. |
|
Shareholder |
|
Against |
|
For |
|
MEDICAL PROPERTIES TRUST, INC.
| Security |
58463J304 |
Meeting Type |
Annual |
| Ticker Symbol |
MPW |
Meeting Date |
25-May-2023 |
| Record Date |
29-Mar-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1.1 |
|
Election of Director: Edward
K. Aldag, Jr. |
|
Management |
|
For |
|
For |
|
| 1.2 |
|
Election of Director: G.
Steven Dawson |
|
Management |
|
For |
|
For |
|
| 1.3 |
|
Election of Director: R.
Steven Hamner |
|
Management |
|
For |
|
For |
|
| 1.4 |
|
Election of Director: Caterina
A. Mozingo |
|
Management |
|
For |
|
For |
|
| 1.5 |
|
Election of Director: Emily
W. Murphy |
|
Management |
|
For |
|
For |
|
| 1.6 |
|
Election of Director: Elizabeth
N. Pitman |
|
Management |
|
For |
|
For |
|
| 1.7 |
|
Election of Director: D.
Paul Sparks, Jr. |
|
Management |
|
For |
|
For |
|
| 1.8 |
|
Election of Director: Michael
G. Stewart |
|
Management |
|
For |
|
For |
|
| 1.9 |
|
Election of Director: C.
Reynolds Thompson, III |
|
Management |
|
For |
|
For |
|
| 2. |
|
To ratify the appointment
of PricewaterhouseCoopers LLP as independent registered public accounting firm for the fiscal year ending December 31, 2023. |
|
Management |
|
For |
|
For |
|
| 3. |
|
To approve, on a non-binding,
advisory basis, the compensation of the Company's named executive officers. |
|
Management |
|
For |
|
For |
|
| 4. |
|
To recommend, on a non-binding,
advisory basis, the frequency of future advisory votes on executive compensation. |
|
Management |
|
1 Year |
|
For |
|
MEDTRONIC PLC
| Security |
G5960L103 |
Meeting Type |
Annual |
| Ticker Symbol |
MDT |
Meeting Date |
08-Dec-2022 |
| Record Date |
11-Oct-2022 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a. |
|
Election of Director to
hold office until the 2023 Annual General Meeting: Richard H. Anderson |
|
Management |
|
For |
|
For |
|
| 1b. |
|
Election of Director to
hold office until the 2023 Annual General Meeting: Craig Arnold |
|
Management |
|
For |
|
For |
|
| 1c. |
|
Election of Director to
hold office until the 2023 Annual General Meeting: Scott C. Donnelly |
|
Management |
|
For |
|
For |
|
| 1d. |
|
Election of Director to
hold office until the 2023 Annual General Meeting: Lidia L. Fonseca |
|
Management |
|
For |
|
For |
|
| 1e. |
|
Election of Director to
hold office until the 2023 Annual General Meeting: Andrea J. Goldsmith, Ph.D. |
|
Management |
|
For |
|
For |
|
| 1f. |
|
Election of Director to
hold office until the 2023 Annual General Meeting: Randall J. Hogan, III |
|
Management |
|
For |
|
For |
|
| 1g. |
|
Election of Director to
hold office until the 2023 Annual General Meeting: Kevin E. Lofton |
|
Management |
|
For |
|
For |
|
| 1h. |
|
Election of Director to
hold office until the 2023 Annual General Meeting: Geoffrey S. Martha |
|
Management |
|
For |
|
For |
|
| 1i. |
|
Election of Director to
hold office until the 2023 Annual General Meeting: Elizabeth G. Nabel, M.D. |
|
Management |
|
For |
|
For |
|
| 1j. |
|
Election of Director to
hold office until the 2023 Annual General Meeting: Denise M. O'Leary |
|
Management |
|
For |
|
For |
|
| 1k. |
|
Election of Director to
hold office until the 2023 Annual General Meeting: Kendall J. Powell |
|
Management |
|
For |
|
For |
|
| 2. |
|
Ratifying, in a non-binding
vote, the appointment of PricewaterhouseCoopers LLP as the Company's independent auditor for fiscal year 2023 and authorizing, in
a binding vote, the Board of Directors, acting through the Audit Committee, to set the auditor's remuneration. |
|
Management |
|
For |
|
For |
|
| 3. |
|
Approving, on an advisory
basis, the Company's executive compensation. |
|
Management |
|
For |
|
For |
|
| 4. |
|
Renewing the Board of Directors'
authority to issue shares under Irish law. |
|
Management |
|
For |
|
For |
|
| 5. |
|
Renewing the Board of Directors'
authority to opt out of pre-emption rights under Irish law. |
|
Management |
|
For |
|
For |
|
| 6. |
|
Authorizing the Company
and any subsidiary of the Company to make overseas market purchases of Medtronic ordinary shares. |
|
Management |
|
For |
|
For |
|
MERCK & CO., INC.
| Security |
58933Y105 |
Meeting Type |
Annual |
| Ticker Symbol |
MRK |
Meeting Date |
23-May-2023 |
| Record Date |
24-Mar-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a. |
|
Election of Director: Douglas
M. Baker, Jr. |
|
Management |
|
For |
|
For |
|
| 1b. |
|
Election of Director: Mary
Ellen Coe |
|
Management |
|
For |
|
For |
|
| 1c. |
|
Election of Director: Pamela
J. Craig |
|
Management |
|
For |
|
For |
|
| 1d. |
|
Election of Director: Robert
M. Davis |
|
Management |
|
For |
|
For |
|
| 1e. |
|
Election of Director: Thomas
H. Glocer |
|
Management |
|
For |
|
For |
|
| 1f. |
|
Election of Director: Risa
J. Lavizzo-Mourey, M.D. |
|
Management |
|
For |
|
For |
|
| 1g. |
|
Election of Director: Stephen
L. Mayo, Ph.D. |
|
Management |
|
For |
|
For |
|
| 1h. |
|
Election of Director: Paul
B. Rothman, M.D. |
|
Management |
|
For |
|
For |
|
| 1i. |
|
Election of Director: Patricia
F. Russo |
|
Management |
|
For |
|
For |
|
| 1j. |
|
Election of Director: Christine
E. Seidman, M.D. |
|
Management |
|
For |
|
For |
|
| 1k. |
|
Election of Director: Inge
G. Thulin |
|
Management |
|
For |
|
For |
|
| 1l. |
|
Election of Director: Kathy
J. Warden |
|
Management |
|
For |
|
For |
|
| 1m. |
|
Election of Director: Peter
C. Wendell |
|
Management |
|
For |
|
For |
|
| 2. |
|
Non-binding advisory vote
to approve the compensation of our named executive officers. |
|
Management |
|
For |
|
For |
|
| 3. |
|
Non-binding advisory vote
to approve the frequency of future votes to approve the compensation of our named executive officers. |
|
Management |
|
1 Year |
|
For |
|
| 4. |
|
Ratification of the appointment
of the Company's independent registered public accounting firm for 2023. |
|
Management |
|
For |
|
For |
|
| 5. |
|
Shareholder proposal regarding
business operations in China. |
|
Shareholder |
|
Against |
|
For |
|
| 6. |
|
Shareholder proposal regarding
access to COVID-19 products. |
|
Shareholder |
|
Against |
|
For |
|
| 7. |
|
Shareholder proposal regarding
indirect political spending. |
|
Shareholder |
|
Against |
|
For |
|
| 8. |
|
Shareholder proposal regarding
patents and access. |
|
Shareholder |
|
Against |
|
For |
|
| 9. |
|
Shareholder proposal regarding
a congruency report of partnerships with globalist organizations. |
|
Shareholder |
|
Against |
|
For |
|
| 10. |
|
Shareholder proposal regarding
an independent board chairman. |
|
Shareholder |
|
For |
|
Against |
|
MODERNA, INC.
| Security |
60770K107 |
Meeting Type |
Annual |
| Ticker Symbol |
MRNA |
Meeting Date |
03-May-2023 |
| Record Date |
08-Mar-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1. |
|
DIRECTOR |
|
Management |
|
|
|
|
|
| |
|
1 |
Stephen Berenson |
|
|
|
For |
|
For |
|
| |
|
2 |
Sandra Horning, M.D. |
|
|
|
For |
|
For |
|
| |
|
3 |
Paul Sagan |
|
|
|
For |
|
For |
|
| 2. |
|
To approve,
on a non-binding, advisory basis, the compensation of our named executive officers. |
|
Management |
|
For |
|
For |
|
| 3. |
|
To ratify the
appointment of Ernst & Young LLP as our registered independent public accounting firm for the year ending December 31, 2023. |
|
Management |
|
For |
|
For |
|
| 4. |
|
To vote on
a shareholder proposal requesting a report on transferring intellectual property. |
|
Shareholder |
|
Against |
|
For |
|
MOLINA HEALTHCARE, INC.
| Security |
60855R100 |
Meeting Type |
Annual |
| Ticker Symbol |
MOH |
Meeting Date |
03-May-2023 |
| Record Date |
08-Mar-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a. |
|
Election of Director to
hold office until the 2024 Annual Meeting: Barbara L. Brasier |
|
Management |
|
For |
|
For |
|
| 1b. |
|
Election of Director to
hold office until the 2024 Annual Meeting: Daniel Cooperman |
|
Management |
|
For |
|
For |
|
| 1c. |
|
Election of Director to
hold office until the 2024 Annual Meeting: Stephen H. Lockhart |
|
Management |
|
For |
|
For |
|
| 1d. |
|
Election of Director to
hold office until the 2024 Annual Meeting: Steven J. Orlando |
|
Management |
|
For |
|
For |
|
| 1e. |
|
Election of Director to
hold office until the 2024 Annual Meeting: Ronna E. Romney |
|
Management |
|
For |
|
For |
|
| 1f. |
|
Election of Director to
hold office until the 2024 Annual Meeting: Richard M. Schapiro |
|
Management |
|
For |
|
For |
|
| 1g. |
|
Election of Director to
hold office until the 2024 Annual Meeting: Dale B. Wolf |
|
Management |
|
For |
|
For |
|
| 1h. |
|
Election of Director to
hold office until the 2024 Annual Meeting: Richard C. Zoretic |
|
Management |
|
For |
|
For |
|
| 1i. |
|
Election of Director to
hold office until the 2024 Annual Meeting: Joseph M. Zubretsky |
|
Management |
|
For |
|
For |
|
| 2. |
|
To consider and approve,
on a non-binding, advisory basis, the compensation of our named executive officers. |
|
Management |
|
For |
|
For |
|
| 3. |
|
To conduct an advisory
vote on the frequency of a stockholder vote on the compensation of our named executive officers. |
|
Management |
|
1 Year |
|
For |
|
| 4. |
|
To ratify the appointment
of Ernst & Young LLP as our independent registered public accounting firm for 2023. |
|
Management |
|
For |
|
For |
|
NATIONAL HEALTH INVESTORS, INC.
| Security |
63633D104 |
Meeting Type |
Annual |
| Ticker Symbol |
NHI |
Meeting Date |
05-May-2023 |
| Record Date |
10-Mar-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a. |
|
Election of Director: W.
Andrew Adams |
|
Management |
|
For |
|
For |
|
| 1b. |
|
Election of Director: Tracy
M.J. Colden |
|
Management |
|
For |
|
For |
|
| 1c. |
|
Election of Director: Robert
A. McCabe, Jr. |
|
Management |
|
For |
|
For |
|
| 2. |
|
Approve the Amended and
Restated 2019 Stock Incentive Plan. |
|
Management |
|
For |
|
For |
|
| 3. |
|
Approve the advisory resolution
approving the compensation of the named executive officers as disclosed in the accompanying Proxy Statement. |
|
Management |
|
For |
|
For |
|
| 4. |
|
Approve the advisory vote
on the frequency of the advisory vote on the compensation of the named executive officers. |
|
Management |
|
1 Year |
|
For |
|
| 5. |
|
Ratify the audit committee's
selection of BDO USA, LLP as independent registered public accounting firm for the year ending December 31, 2023. |
|
Management |
|
For |
|
For |
|
OCULIS HOLDING AG
| Security |
N/A |
Meeting Type |
Written Consent |
| Ticker Symbol |
N/A |
Meeting Date |
8-Jul-2022 |
| Record Date |
N/A |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1 |
|
Change of Designation of
the Existing Series C Preferred Shares and Revision of the Articles of Association |
|
Management |
|
For |
|
For |
|
| 2. |
|
Ordinary Share Capital
Increase |
|
Management |
|
For |
|
For |
|
| 3. |
|
Conditional Share Capital
Increase |
|
Management |
|
For |
|
For |
|
| 4. |
|
Election of Member to the
Board of Directors |
|
Management |
|
For |
|
For |
|
OMEGA HEALTHCARE INVESTORS, INC.
| Security |
681936100 |
Meeting Type |
Annual |
| Ticker Symbol |
OHI |
Meeting Date |
05-Jun-2023 |
| Record Date |
06-Apr-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a. |
|
Election of Director: Kapila
K. Anand |
|
Management |
|
For |
|
For |
|
| 1b. |
|
Election of Director: Craig
R. Callen |
|
Management |
|
For |
|
For |
|
| 1c. |
|
Election of Director: Dr.
Lisa C. Egbuonu-Davis |
|
Management |
|
For |
|
For |
|
| 1d. |
|
Election of Director: Barbara
B. Hill |
|
Management |
|
For |
|
For |
|
| 1e. |
|
Election of Director: Kevin
J. Jacobs |
|
Management |
|
For |
|
For |
|
| 1f. |
|
Election of Director: C.
Taylor Pickett |
|
Management |
|
For |
|
For |
|
| 1g. |
|
Election of Director: Stephen
D. Plavin |
|
Management |
|
For |
|
For |
|
| 1h. |
|
Election of Director: Burke
W. Whitman |
|
Management |
|
For |
|
For |
|
| 2. |
|
Ratification of Independent
Auditors Ernst & Young LLP for fiscal year 2023. |
|
Management |
|
For |
|
For |
|
| 3. |
|
Approval, on an Advisory
Basis, of Executive Compensation. |
|
Management |
|
For |
|
For |
|
| 4. |
|
Advisory Vote on Frequency
of Advisory Votes on Executive Compensation. |
|
Management |
|
1 Year |
|
For |
|
| 5. |
|
Approval of Amendment to
the Omega Healthcare Investors, Inc. 2018 Stock Incentive Plan to increase the number of shares of Common Stock authorized for issuance
thereunder. |
|
Management |
|
For |
|
For |
|
OPTION CARE HEALTH, INC.
| Security |
68404L201 |
Meeting Type |
Annual |
| Ticker Symbol |
OPCH |
Meeting Date |
17-May-2023 |
| Record Date |
22-Mar-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1. |
|
DIRECTOR |
|
Management |
|
|
|
|
|
| |
|
1 |
John J. Arlotta |
|
|
|
For |
|
For |
|
| |
|
2 |
Elizabeth Q. Betten |
|
|
|
For |
|
For |
|
| |
|
3 |
Elizabeth D. Bierbower |
|
|
|
For |
|
For |
|
| |
|
4 |
Natasha Deckmann |
|
|
|
For |
|
For |
|
| |
|
5 |
David W. Golding |
|
|
|
For |
|
For |
|
| |
|
6 |
Harry M. J. Kraemer Jr. |
|
|
|
For |
|
For |
|
| |
|
7 |
R. Carter Pate |
|
|
|
For |
|
For |
|
| |
|
8 |
John C. Rademacher |
|
|
|
For |
|
For |
|
| |
|
9 |
Nitin Sahney |
|
|
|
For |
|
For |
|
| |
|
10 |
Timothy P. Sullivan |
|
|
|
For |
|
For |
|
| 2. |
|
To ratify the
appointment of KPMG LLP as our independent registered public accounting firm for the year ending December 31, 2023. |
|
Management |
|
For |
|
For |
|
| 3. |
|
To approve,
on a non-binding advisory basis, our executive compensation. |
|
Management |
|
For |
|
For |
|
| 4. |
|
To conduct
an advisory vote on the frequency of a stockholder vote on our executive compensation. |
|
Management |
|
1 Year |
|
For |
|
PERRIGO COMPANY PLC
| Security |
G97822103 |
Meeting Type |
Annual |
| Ticker Symbol |
PRGO |
Meeting Date |
04-May-2023 |
| Record Date |
06-Mar-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1A. |
|
Election of Director to
hold office until the 2024 Annual General Meeting: Bradley A. Alford |
|
Management |
|
For |
|
For |
|
| 1B. |
|
Election of Director to
hold office until the 2024 Annual General Meeting: Orlando D. Ashford |
|
Management |
|
For |
|
For |
|
| 1C. |
|
Election of Director to
hold office until the 2024 Annual General Meeting: Katherine C. Doyle |
|
Management |
|
For |
|
For |
|
| 1D. |
|
Election of Director to
hold office until the 2024 Annual General Meeting: Adriana Karaboutis |
|
Management |
|
For |
|
For |
|
| 1E. |
|
Election of Director to
hold office until the 2024 Annual General Meeting: Murray S. Kessler |
|
Management |
|
For |
|
For |
|
| 1F. |
|
Election of Director to
hold office until the 2024 Annual General Meeting: Jeffrey B. Kindler |
|
Management |
|
For |
|
For |
|
| 1G. |
|
Election of Director to
hold office until the 2024 Annual General Meeting: Erica L. Mann |
|
Management |
|
For |
|
For |
|
| 1H. |
|
Election of Director to
hold office until the 2024 Annual General Meeting: Albert A. Manzone |
|
Management |
|
For |
|
For |
|
| 1I. |
|
Election of Director to
hold office until the 2024 Annual General Meeting: Donal O'Connor |
|
Management |
|
For |
|
For |
|
| 1J. |
|
Election of Director to
hold office until the 2024 Annual General Meeting: Geoffrey M. Parker |
|
Management |
|
For |
|
For |
|
| 2. |
|
Ratify, in a non-binding
advisory vote, the appointment of Ernst & Young LLP as the Company's independent auditor, and authorize, in a binding vote, the
Board of Directors, acting through the Audit Committee, to fix the remuneration of the auditor |
|
Management |
|
For |
|
For |
|
| 3. |
|
Advisory vote on executive
compensation |
|
Management |
|
For |
|
For |
|
| 4. |
|
Advisory vote on the frequency
of future advisory votes on executive compensation |
|
Management |
|
1 Year |
|
For |
|
| 5. |
|
Renew the Board's authority
to issue shares under Irish law |
|
Management |
|
For |
|
For |
|
| 6. |
|
Renew the Board's authority
to opt-out of statutory pre-emption rights under Irish law |
|
Management |
|
For |
|
For |
|
| 7. |
|
Approve the creation of
distributable reserves by reducing some or all of the Company's share premium |
|
Management |
|
For |
|
For |
|
PFIZER INC.
| Security |
717081103 |
Meeting Type |
Annual |
| Ticker Symbol |
PFE |
Meeting Date |
27-Apr-2023 |
| Record Date |
01-Mar-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a. |
|
Election of Director: Ronald
E. Blaylock |
|
Management |
|
For |
|
For |
|
| 1b. |
|
Election of Director: Albert
Bourla |
|
Management |
|
For |
|
For |
|
| 1c. |
|
Election of Director: Susan
Desmond-Hellmann |
|
Management |
|
For |
|
For |
|
| 1d. |
|
Election of Director: Joseph
J. Echevarria |
|
Management |
|
For |
|
For |
|
| 1e. |
|
Election of Director: Scott
Gottlieb |
|
Management |
|
For |
|
For |
|
| 1f. |
|
Election of Director: Helen
H. Hobbs |
|
Management |
|
For |
|
For |
|
| 1g. |
|
Election of Director: Susan
Hockfield |
|
Management |
|
For |
|
For |
|
| 1h. |
|
Election of Director: Dan
R. Littman |
|
Management |
|
For |
|
For |
|
| 1i. |
|
Election of Director: Shantanu
Narayen |
|
Management |
|
For |
|
For |
|
| 1j. |
|
Election of Director: Suzanne
Nora Johnson |
|
Management |
|
For |
|
For |
|
| 1k. |
|
Election of Director: James
Quincey |
|
Management |
|
For |
|
For |
|
| 1l. |
|
Election of Director: James
C. Smith |
|
Management |
|
For |
|
For |
|
| 2. |
|
Ratify the selection of
KPMG LLP as independent registered public accounting firm for 2023 |
|
Management |
|
For |
|
For |
|
| 3. |
|
2023 advisory approval
of executive compensation |
|
Management |
|
For |
|
For |
|
| 4. |
|
Advisory vote on frequency
of future advisory votes to approve executive compensation |
|
Management |
|
1 Year |
|
For |
|
| 5. |
|
Shareholder proposal regarding
ratification of termination pay |
|
Shareholder |
|
Against |
|
For |
|
| 6. |
|
Shareholder proposal regarding
independent board chairman policy |
|
Shareholder |
|
For |
|
Against |
|
| 7. |
|
Shareholder proposal regarding
transfer of intellectual property to potential COVID-19 manufacturers feasibility report |
|
Shareholder |
|
Against |
|
For |
|
| 8. |
|
Shareholder proposal regarding
impact of extended patent exclusivities on product access report |
|
Shareholder |
|
Against |
|
For |
|
| 9. |
|
Shareholder proposal regarding
political contributions congruency report |
|
Shareholder |
|
Against |
|
For |
|
PHYSICIANS REALTY TRUST
| Security |
71943U104 |
Meeting Type |
Annual |
| Ticker Symbol |
DOC |
Meeting Date |
03-May-2023 |
| Record Date |
24-Feb-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1.1 |
|
Election of Trustee: John
T. Thomas |
|
Management |
|
For |
|
For |
|
| 1.2 |
|
Election of Trustee: Tommy
G. Thompson |
|
Management |
|
For |
|
For |
|
| 1.3 |
|
Election of Trustee: Stanton
D. Anderson |
|
Management |
|
For |
|
For |
|
| 1.4 |
|
Election of Trustee: Mark
A. Baumgartner |
|
Management |
|
For |
|
For |
|
| 1.5 |
|
Election of Trustee: Albert
C. Black, Jr. |
|
Management |
|
For |
|
For |
|
| 1.6 |
|
Election of Trustee: William
A. Ebinger, M.D. |
|
Management |
|
For |
|
For |
|
| 1.7 |
|
Election of Trustee: Pamela
J. Kessler |
|
Management |
|
For |
|
For |
|
| 1.8 |
|
Election of Trustee: Ava
E. Lias-Booker |
|
Management |
|
For |
|
For |
|
| 1.9 |
|
Election of Trustee: Richard
A. Weiss |
|
Management |
|
For |
|
For |
|
| 2. |
|
To ratify the appointment
of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2023. |
|
Management |
|
For |
|
For |
|
| 3. |
|
To approve, on a non-binding
advisory basis, the compensation of the Company's named executive officers. |
|
Management |
|
For |
|
For |
|
| 4. |
|
To approve the Amended
and Restated Physicians Realty Trust 2013 Equity Incentive Plan. |
|
Management |
|
For |
|
For |
|
| 5. |
|
To approve the Amended
and Restated Physicians Realty Trust 2015 Employee Stock Purchase Plan. |
|
Management |
|
For |
|
For |
|
R1 RCM INC.
| Security |
77634L105 |
Meeting Type |
Annual |
| Ticker Symbol |
RCM |
Meeting Date |
17-May-2023 |
| Record Date |
21-Mar-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1. |
|
DIRECTOR |
|
Management |
|
|
|
|
|
| |
|
1 |
B. Kyle Armbrester |
|
|
|
For |
|
For |
|
| |
|
2 |
Agnes Bundy Scanlan |
|
|
|
For |
|
For |
|
| |
|
3 |
Brian K. Dean |
|
|
|
For |
|
For |
|
| |
|
4 |
Jeremy Delinsky |
|
|
|
For |
|
For |
|
| |
|
5 |
David M. Dill |
|
|
|
For |
|
For |
|
| |
|
6 |
Michael C. Feiner |
|
|
|
For |
|
For |
|
| |
|
7 |
Joseph Flanagan |
|
|
|
For |
|
For |
|
| |
|
8 |
John B. Henneman III |
|
|
|
For |
|
For |
|
| |
|
9 |
Matthew Holt |
|
|
|
For |
|
For |
|
| |
|
10 |
Neal Moszkowski |
|
|
|
For |
|
For |
|
| |
|
11 |
Lee Rivas |
|
|
|
For |
|
For |
|
| |
|
12 |
Ian Sacks |
|
|
|
For |
|
For |
|
| |
|
13 |
Jill Smith |
|
|
|
For |
|
For |
|
| |
|
14 |
Anthony J. Speranzo |
|
|
|
For |
|
For |
|
| |
|
15 |
Anthony R. Tersigni |
|
|
|
For |
|
For |
|
| |
|
16 |
Janie Wade |
|
|
|
For |
|
For |
|
| 2. |
|
To approve
our Fourth Amended and Restated 2010 Stock Incentive Plan to increase the number of shares authorized for issuance under our Third
Amended and Restated 2010 Stock Incentive Plan by 4 million shares. |
|
Management |
|
For |
|
For |
|
| 3. |
|
To approve,
on an advisory basis, the frequency of advisory stockholder votes on the compensation of our Named Executive Officers. |
|
Management |
|
1 Year |
|
Against |
|
| 4. |
|
To ratify the
selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2023. |
|
Management |
|
For |
|
For |
|
RALLYBIO CORPORATION
| Security |
75120L100 |
Meeting Type |
Annual |
| Ticker Symbol |
RLYB |
Meeting Date |
17-May-2023 |
| Record Date |
20-Mar-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1.1 |
|
Election of Class II Director:
Helen M. Boudreau |
|
Management |
|
For |
|
For |
|
| 1.2 |
|
Election of Class II Director:
Lucian Iancovici |
|
Management |
|
For |
|
For |
|
| 1.3 |
|
Election of Class II Director:
Christine A. Nash |
|
Management |
|
For |
|
For |
|
| 2. |
|
Ratification of the appointment
of Deloitte & Touche LLP as the independent registered public accounting firm. |
|
Management |
|
For |
|
For |
|
REGENERON PHARMACEUTICALS, INC.
| Security |
75886F107 |
Meeting Type |
Annual |
| Ticker Symbol |
REGN |
Meeting Date |
09-Jun-2023 |
| Record Date |
11-Apr-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a. |
|
Election of Director: Joseph
L. Goldstein, M.D. |
|
Management |
|
For |
|
For |
|
| 1b. |
|
Election of Director: Christine
A. Poon |
|
Management |
|
For |
|
For |
|
| 1c. |
|
Election of Director: Craig
B. Thompson, M.D. |
|
Management |
|
For |
|
For |
|
| 1d. |
|
Election of Director: Huda
Y. Zoghbi, M.D. |
|
Management |
|
For |
|
For |
|
| 2. |
|
Ratification of the appointment
of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December
31, 2023. |
|
Management |
|
For |
|
For |
|
| 3. |
|
Proposal to approve, on
an advisory basis, executive compensation. |
|
Management |
|
For |
|
For |
|
| 4. |
|
Proposal to approve, on
an advisory basis, the frequency of future advisory votes on executive compensation. |
|
Management |
|
1 Year |
|
For |
|
| 5. |
|
Non-binding shareholder
proposal, if properly presented, requesting report on a process by which access to medicine is considered in matters related to protecting
intellectual property. |
|
Shareholder |
|
Against |
|
For |
|
RESMED INC.
| Security |
761152107 |
Meeting Type |
Annual |
| Ticker Symbol |
RMD |
Meeting Date |
16-Nov-2022 |
| Record Date |
20-Sep-2022 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a. |
|
Election of Director to
serve until our 2023 annual meeting: Carol Burt |
|
Management |
|
For |
|
For |
|
| 1b. |
|
Election of Director to
serve until our 2023 annual meeting: Jan De Witte |
|
Management |
|
For |
|
For |
|
| 1c. |
|
Election of Director to
serve until our 2023 annual meeting: Karen Drexler |
|
Management |
|
For |
|
For |
|
| 1d. |
|
Election of Director to
serve until our 2023 annual meeting: Michael Farrell |
|
Management |
|
For |
|
For |
|
| 1e. |
|
Election of Director to
serve until our 2023 annual meeting: Peter Farrell |
|
Management |
|
For |
|
For |
|
| 1f. |
|
Election of Director to
serve until our 2023 annual meeting: Harjit Gill |
|
Management |
|
For |
|
For |
|
| 1g. |
|
Election of Director to
serve until our 2023 annual meeting: John Hernandez |
|
Management |
|
For |
|
For |
|
| 1h. |
|
Election of Director to
serve until our 2023 annual meeting: Richard Sulpizio |
|
Management |
|
For |
|
For |
|
| 1i. |
|
Election of Director to
serve until our 2023 annual meeting: Desney Tan |
|
Management |
|
For |
|
For |
|
| 1j. |
|
Election of Director to
serve until our 2023 annual meeting: Ronald Taylor |
|
Management |
|
For |
|
For |
|
| 2. |
|
Ratify our selection of
KPMG LLP as our independent registered public accounting firm for the fiscal year ending June 30, 2023. |
|
Management |
|
For |
|
For |
|
| 3. |
|
Approve, on an advisory
basis, the compensation paid to our named executive officers, as disclosed in the proxy statement ("say-on-pay"). |
|
Management |
|
For |
|
For |
|
SABRA HEALTH CARE REIT, INC.
| Security |
78573L106 |
Meeting Type |
Annual |
| Ticker Symbol |
SBRA |
Meeting Date |
14-Jun-2023 |
| Record Date |
18-Apr-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a. |
|
Election of Director: Craig
A. Barbarosh |
|
Management |
|
For |
|
For |
|
| 1b. |
|
Election of Director: Katie
Cusack |
|
Management |
|
For |
|
For |
|
| 1c. |
|
Election of Director: Michael
J. Foster |
|
Management |
|
For |
|
For |
|
| 1d. |
|
Election of Director: Lynne
S. Katzmann |
|
Management |
|
For |
|
For |
|
| 1e. |
|
Election of Director: Ann
Kono |
|
Management |
|
For |
|
For |
|
| 1f. |
|
Election of Director: Jeffrey
A. Malehorn |
|
Management |
|
For |
|
For |
|
| 1g. |
|
Election of Director: Richard
K. Matros |
|
Management |
|
For |
|
For |
|
| 1h. |
|
Election of Director: Clifton
J. Porter II |
|
Management |
|
For |
|
For |
|
| 2. |
|
Ratification of the appointment
of PricewaterhouseCoopers LLP as Sabra's independent registered public accounting firm for the fiscal year ending December 31, 2023. |
|
Management |
|
For |
|
For |
|
| 3. |
|
Approval, on an advisory
basis, of the compensation of Sabra's named executive officers. |
|
Management |
|
For |
|
For |
|
| 4. |
|
Approval, on an advisory
basis, of the frequency of future advisory votes on executive compensation. |
|
Management |
|
1 Year |
|
For |
|
SAREPTA THERAPEUTICS, INC.
| Security |
803607100 |
Meeting Type |
Annual |
| Ticker Symbol |
SRPT |
Meeting Date |
08-Jun-2023 |
| Record Date |
14-Apr-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1.1 |
|
Election of Class II Director
to hold office until the 2025 Annual Meeting: Richard J. Barry |
|
Management |
|
For |
|
For |
|
| 1.2 |
|
Election of Class II Director
to hold office until the 2025 Annual Meeting: M. Kathleen Behrens, Ph.D. |
|
Management |
|
For |
|
For |
|
| 1.3 |
|
Election of Class II Director
to hold office until the 2025 Annual Meeting: Stephen L. Mayo, Ph. D. |
|
Management |
|
For |
|
For |
|
| 1.4 |
|
Election of Class II Director
to hold office until the 2025 Annual Meeting: Claude Nicaise, M.D. |
|
Management |
|
For |
|
For |
|
| 2. |
|
Advisory vote to approve,
on a non-binding basis, named executive officer compensation |
|
Management |
|
For |
|
For |
|
| 3. |
|
Approve an amendment to
the Company's 2018 Equity Incentive Plan (the "2018 Plan") to increase the maximum aggregate number of shares of common
stock that may be issued pursuant to awards granted under the 2018 Plan by 2,500,000 shares to 13,187,596 shares |
|
Management |
|
For |
|
For |
|
| 4. |
|
Approve an amendment to
the Amended and Restated 2013 Employee Stock Purchase Plan (as amended and restated on June 27, 2016 and amended on June 6, 2019)
(the "2016 ESPP") to increase the number of shares of our common stock authorized for issuance under the 2016 ESPP by 300,000
shares to 1,400,000 shares |
|
Management |
|
For |
|
For |
|
| 5. |
|
Advisory vote on whether
an advisory vote on executive compensation should be held every one, two or three years |
|
Management |
|
1 Year |
|
For |
|
| 6. |
|
Ratify the selection of
KPMG LLP as the Company's independent registered public accounting firm for the current year ending December 31, 2023 |
|
Management |
|
For |
|
For |
|
STERIS PLC
| Security |
G8473T100 |
Meeting Type |
Annual |
| Ticker Symbol |
STE |
Meeting Date |
28-Jul-2022 |
| Record Date |
01-Jun-2022 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a. |
|
Re-election of Director:
Richard C. Breeden |
|
Management |
|
For |
|
For |
|
| 1b. |
|
Re-election of Director:
Daniel A. Carestio |
|
Management |
|
For |
|
For |
|
| 1c. |
|
Re-election of Director:
Cynthia L. Feldmann |
|
Management |
|
For |
|
For |
|
| 1d. |
|
Re-election of Director:
Christopher S. Holland |
|
Management |
|
For |
|
For |
|
| 1e. |
|
Re-election of Director:
Dr. Jacqueline B. Kosecoff |
|
Management |
|
For |
|
For |
|
| 1f. |
|
Re-election of Director:
Paul E. Martin |
|
Management |
|
For |
|
For |
|
| 1g. |
|
Re-election of Director:
Dr. Nirav R. Shah |
|
Management |
|
For |
|
For |
|
| 1h. |
|
Re-election of Director:
Dr. Mohsen M. Sohi |
|
Management |
|
For |
|
For |
|
| 1i. |
|
Re-election of Director:
Dr. Richard M. Steeves |
|
Management |
|
For |
|
For |
|
| 2. |
|
To ratify the appointment
of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending March 31, 2023. |
|
Management |
|
For |
|
For |
|
| 3. |
|
To appoint Ernst &
Young Chartered Accountants as the Company's statutory auditor under Irish law to hold office until the conclusion of the Company's
next annual general meeting. |
|
Management |
|
For |
|
For |
|
| 4. |
|
To authorize the Board
of Directors of the Company or the Audit Committee of the Board of Directors to determine the remuneration of Ernst & Young Chartered
Accountants as the Company's statutory auditor under Irish law. |
|
Management |
|
For |
|
For |
|
| 5. |
|
To approve, on a non-binding
advisory basis, the compensation of the Company's named executive officers as disclosed pursuant to the disclosure rules of the U.S.
Securities and Exchange Commission, including the compensation discussion and analysis and the tabular and narrative disclosure contained
in the Company's proxy statement dated June 14, 2022. |
|
Management |
|
For |
|
For |
|
STRYKER CORPORATION
| Security |
863667101 |
Meeting Type |
Annual |
| Ticker Symbol |
SYK |
Meeting Date |
10-May-2023 |
| Record Date |
13-Mar-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a. |
|
Election of Director: Mary
K. Brainerd |
|
Management |
|
For |
|
For |
|
| 1b. |
|
Election of Director: Giovanni
Caforio, M.D. |
|
Management |
|
For |
|
For |
|
| 1c. |
|
Election of Director: Srikant
M. Datar, Ph.D. |
|
Management |
|
For |
|
For |
|
| 1d. |
|
Election of Director: Allan
C. Golston |
|
Management |
|
For |
|
For |
|
| 1e. |
|
Election of Director: Kevin
A. Lobo (Chair of the Board, Chief Executive Officer and President) |
|
Management |
|
For |
|
For |
|
| 1f. |
|
Election of Director: Sherilyn
S. McCoy (Lead Independent Director) |
|
Management |
|
For |
|
For |
|
| 1g. |
|
Election of Director: Andrew
K. Silvernail |
|
Management |
|
For |
|
For |
|
| 1h. |
|
Election of Director: Lisa
M. Skeete Tatum |
|
Management |
|
For |
|
For |
|
| 1i. |
|
Election of Director: Ronda
E. Stryker |
|
Management |
|
For |
|
For |
|
| 1j. |
|
Election of Director: Rajeev
Suri |
|
Management |
|
For |
|
For |
|
| 2. |
|
Ratification of Appointment
of Ernst & Young LLP as Our Independent Registered Public Accounting Firm for 2023. |
|
Management |
|
For |
|
For |
|
| 3. |
|
Advisory Vote to Approve
Named Executive Officer Compensation. |
|
Management |
|
For |
|
For |
|
| 4. |
|
Advisory Vote on the Frequency
of Future Advisory Votes on Named Executive Officer Compensation. |
|
Management |
|
1 Year |
|
For |
|
| 5. |
|
Shareholder Proposal on
Political Disclosure. |
|
Shareholder |
|
Against |
|
For |
|
TEVA PHARMACEUTICAL INDUSTRIES LIMITED
| Security |
881624209 |
Meeting Type |
Annual |
| Ticker Symbol |
TEVA |
Meeting Date |
15-Jun-2023 |
| Record Date |
10-Apr-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1A. |
|
Election of Director: Dr.
Sol J. Barer |
|
Management |
|
For |
|
For |
|
| 1B. |
|
Election of Director: M.
Braverman-Blumenstyk |
|
Management |
|
For |
|
For |
|
| 1C. |
|
Election of Director: Janet
S. Vergis |
|
Management |
|
For |
|
For |
|
| 2. |
|
To approve, on a non-binding
advisory basis, the compensation for Teva's named executive officers. |
|
Management |
|
For |
|
For |
|
| 3. |
|
To appoint Kesselman &
Kesselman, a member of PricewaterhouseCoopers International Ltd., as Teva's independent registered public accounting firm until Teva's
2024 annual meeting of shareholders. |
|
Management |
|
For |
|
For |
|
TEVA PHARMACEUTICAL INDUSTRIES LIMITED
| Security |
881624209 |
Meeting Type |
Annual |
| Ticker Symbol |
TEVA |
Meeting Date |
15-Jun-2023 |
| Record Date |
08-May-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1A. |
|
Election of Director: Dr.
Sol J. Barer |
|
Management |
|
For |
|
For |
|
| 1B. |
|
Election of Director: M.
Braverman-Blumenstyk |
|
Management |
|
For |
|
For |
|
| 1C. |
|
Election of Director: Janet
S. Vergis |
|
Management |
|
For |
|
For |
|
| 2. |
|
To approve, on a non-binding
advisory basis, the compensation for Teva's named executive officers. |
|
Management |
|
For |
|
For |
|
| 3. |
|
To appoint Kesselman &
Kesselman, a member of PricewaterhouseCoopers International Ltd., as Teva's independent registered public accounting firm until Teva's
2024 annual meeting of shareholders. |
|
Management |
|
For |
|
For |
|
THE CIGNA GROUP
| Security |
125523100 |
Meeting Type |
Annual |
| Ticker Symbol |
CI |
Meeting Date |
26-Apr-2023 |
| Record Date |
07-Mar-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a. |
|
Election of Director: David
M. Cordani |
|
Management |
|
For |
|
For |
|
| 1b. |
|
Election of Director: William
J. DeLaney |
|
Management |
|
For |
|
For |
|
| 1c. |
|
Election of Director: Eric
J. Foss |
|
Management |
|
For |
|
For |
|
| 1d. |
|
Election of Director: Retired
Maj. Gen. Elder Granger, M.D. |
|
Management |
|
For |
|
For |
|
| 1e. |
|
Election of Director: Neesha
Hathi |
|
Management |
|
For |
|
For |
|
| 1f. |
|
Election of Director: George
Kurian |
|
Management |
|
For |
|
For |
|
| 1g. |
|
Election of Director: Kathleen
M. Mazzarella |
|
Management |
|
For |
|
For |
|
| 1h. |
|
Election of Director: Mark
B. McClellan, M.D., Ph.D. |
|
Management |
|
For |
|
For |
|
| 1i. |
|
Election of Director: Kimberly
A. Ross |
|
Management |
|
For |
|
For |
|
| 1j. |
|
Election of Director: Eric
C. Wiseman |
|
Management |
|
For |
|
For |
|
| 1k. |
|
Election of Director: Donna
F. Zarcone |
|
Management |
|
For |
|
For |
|
| 2. |
|
Advisory approval of The
Cigna Group's executive compensation |
|
Management |
|
For |
|
For |
|
| 3. |
|
Advisory approval of the
frequency of future advisory votes on executive compensation |
|
Management |
|
1 Year |
|
For |
|
| 4. |
|
Ratification of the appointment
of PricewaterhouseCoopers LLP as The Cigna Group's independent registered public accounting firm for 2023 |
|
Management |
|
For |
|
For |
|
| 5. |
|
Approval of an amendment
to our Restated Certificate of Incorporation to limit the liability of certain officers of the Company as permitted pursuant to recent
amendments to the Delaware General Corporation Law |
|
Management |
|
For |
|
For |
|
| 6. |
|
Shareholder proposal -
Special shareholder meeting improvement |
|
Shareholder |
|
Against |
|
For |
|
| 7. |
|
Shareholder proposal -
Political contributions report |
|
Shareholder |
|
Against |
|
For |
|
THERMO FISHER SCIENTIFIC INC.
| Security |
883556102 |
Meeting Type |
Annual |
| Ticker Symbol |
TMO |
Meeting Date |
24-May-2023 |
| Record Date |
27-Mar-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a. |
|
Election of Director: Marc
N. Casper |
|
Management |
|
For |
|
For |
|
| 1b. |
|
Election of Director: Nelson
J. Chai |
|
Management |
|
For |
|
For |
|
| 1c. |
|
Election of Director: Ruby
R. Chandy |
|
Management |
|
For |
|
For |
|
| 1d. |
|
Election of Director: C.
Martin Harris |
|
Management |
|
For |
|
For |
|
| 1e. |
|
Election of Director: Tyler
Jacks |
|
Management |
|
For |
|
For |
|
| 1f. |
|
Election of Director: R.
Alexandra Keith |
|
Management |
|
For |
|
For |
|
| 1g. |
|
Election of Director: James
C. Mullen |
|
Management |
|
For |
|
For |
|
| 1h. |
|
Election of Director: Lars
R. Sørensen |
|
Management |
|
For |
|
For |
|
| 1i. |
|
Election of Director: Debora
L. Spar |
|
Management |
|
For |
|
For |
|
| 1j. |
|
Election of Director: Scott
M. Sperling |
|
Management |
|
For |
|
For |
|
| 1k. |
|
Election of Director: Dion
J. Weisler |
|
Management |
|
For |
|
For |
|
| 2. |
|
An advisory vote to approve
named executive officer compensation. |
|
Management |
|
For |
|
For |
|
| 3. |
|
An advisory vote on the
frequency of future named executive officer advisory votes. |
|
Management |
|
1 Year |
|
For |
|
| 4. |
|
Ratification of the Audit
Committee's selection of PricewaterhouseCoopers LLP as the Company's independent auditors for 2023. |
|
Management |
|
For |
|
For |
|
| 5. |
|
Approval of the Company's
Amended and Restated 2013 Stock Incentive Plan. |
|
Management |
|
For |
|
For |
|
| 6. |
|
Approval of the Company's
2023 Global Employee Stock Purchase Plan. |
|
Management |
|
For |
|
For |
|
UNITED THERAPEUTICS CORPORATION
| Security |
91307C102 |
Meeting Type |
Annual |
| Ticker Symbol |
UTHR |
Meeting Date |
26-Jun-2023 |
| Record Date |
27-Apr-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a. |
|
Election of Director: Christopher
Causey |
|
Management |
|
For |
|
For |
|
| 1b. |
|
Election of Director: Raymond
Dwek |
|
Management |
|
For |
|
For |
|
| 1c. |
|
Election of Director: Richard
Giltner |
|
Management |
|
For |
|
For |
|
| 1d. |
|
Election of Director: Katherine
Klein |
|
Management |
|
For |
|
For |
|
| 1e. |
|
Election of Director: Ray
Kurzweil |
|
Management |
|
For |
|
For |
|
| 1f. |
|
Election of Director: Linda
Maxwell |
|
Management |
|
For |
|
For |
|
| 1g. |
|
Election of Director: Nilda
Mesa |
|
Management |
|
For |
|
For |
|
| 1h. |
|
Election of Director: Judy
Olian |
|
Management |
|
For |
|
For |
|
| 1i. |
|
Election of Director: Christopher
Patusky |
|
Management |
|
For |
|
For |
|
| 1j. |
|
Election of Director: Martine
Rothblatt |
|
Management |
|
For |
|
For |
|
| 1k. |
|
Election of Director: Louis
Sullivan |
|
Management |
|
For |
|
For |
|
| 1l. |
|
Election of Director: Tommy
Thompson |
|
Management |
|
For |
|
For |
|
| 2. |
|
Advisory resolution to
approve executive compensation. |
|
Management |
|
For |
|
For |
|
| 3. |
|
Advisory vote on the frequency
of future advisory votes on executive compensation. |
|
Management |
|
1 Year |
|
For |
|
| 4. |
|
Approval of the amendment
and restatement of the United Therapeutics Corporation Amended and Restated 2015 Stock Incentive Plan. |
|
Management |
|
For |
|
For |
|
| 5. |
|
Ratification of the appointment
of Ernst & Young LLP as our independent registered public accounting firm for 2023. |
|
Management |
|
For |
|
For |
|
UNITEDHEALTH GROUP INCORPORATED
| Security |
91324P102 |
Meeting Type |
Annual |
| Ticker Symbol |
UNH |
Meeting Date |
05-Jun-2023 |
| Record Date |
10-Apr-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a. |
|
Election of Director: Timothy
Flynn |
|
Management |
|
For |
|
For |
|
| 1b. |
|
Election of Director: Paul
Garcia |
|
Management |
|
For |
|
For |
|
| 1c. |
|
Election of Director: Kristen
Gil |
|
Management |
|
For |
|
For |
|
| 1d. |
|
Election of Director: Stephen
Hemsley |
|
Management |
|
For |
|
For |
|
| 1e. |
|
Election of Director: Michele
Hooper |
|
Management |
|
For |
|
For |
|
| 1f. |
|
Election of Director: F.
William McNabb III |
|
Management |
|
For |
|
For |
|
| 1g. |
|
Election of Director: Valerie
Montgomery Rice, M.D. |
|
Management |
|
For |
|
For |
|
| 1h. |
|
Election of Director: John
Noseworthy, M.D. |
|
Management |
|
For |
|
For |
|
| 1i. |
|
Election of Director: Andrew
Witty |
|
Management |
|
For |
|
For |
|
| 2. |
|
Advisory approval of the
Company's executive compensation. |
|
Management |
|
For |
|
For |
|
| 3. |
|
Advisory approval of the
frequency of holding future say-on-pay votes. |
|
Management |
|
1 Year |
|
For |
|
| 4. |
|
Ratification of the appointment
of Deloitte & Touche LLP as the independent registered public accounting firm for the Company for the year ending December 31,
2023. |
|
Management |
|
For |
|
For |
|
| 5. |
|
If properly presented at
the 2023 Annual Meeting of Shareholders, the shareholder proposal seeking a third-party racial equity audit. |
|
Shareholder |
|
Against |
|
For |
|
| 6. |
|
If properly presented at
the 2023 Annual Meeting of Shareholders, the shareholder proposal requiring a political contributions congruency report. |
|
Shareholder |
|
Against |
|
For |
|
| 7. |
|
If properly presented at
the 2023 Annual Meeting of Shareholders, the shareholder proposal seeking shareholder ratification of termination pay. |
|
Shareholder |
|
Against |
|
For |
|
UNIVERSAL HEALTH REALTY INCOME TRUST
| Security |
91359E105 |
Meeting Type |
Annual |
| Ticker Symbol |
UHT |
Meeting Date |
07-Jun-2023 |
| Record Date |
10-Apr-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1.1 |
|
Election of Trustee: Alan
B. Miller |
|
Management |
|
For |
|
For |
|
| 1.2 |
|
Election of Trustee: Robert
F. McCadden |
|
Management |
|
For |
|
For |
|
| 2. |
|
Advisory (nonbinding) vote
to approve named executive officer compensation. |
|
Management |
|
For |
|
For |
|
| 3. |
|
Advisory (nonbinding) vote
on the frequency of future advisory shareholder votes to approve named executive officer compensation. |
|
Management |
|
1 Year |
|
For |
|
| 4. |
|
Proposal to ratify the
selection of KPMG, LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2023. |
|
Management |
|
For |
|
For |
|
VERTEX PHARMACEUTICALS INCORPORATED
| Security |
92532F100 |
Meeting Type |
Annual |
| Ticker Symbol |
VRTX |
Meeting Date |
17-May-2023 |
| Record Date |
23-Mar-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1.1 |
|
Election of Director: Sangeeta
Bhatia |
|
Management |
|
For |
|
For |
|
| 1.2 |
|
Election of Director: Lloyd
Carney |
|
Management |
|
For |
|
For |
|
| 1.3 |
|
Election of Director: Alan
Garber |
|
Management |
|
For |
|
For |
|
| 1.4 |
|
Election of Director: Terrence
Kearney |
|
Management |
|
For |
|
For |
|
| 1.5 |
|
Election of Director: Reshma
Kewalramani |
|
Management |
|
For |
|
For |
|
| 1.6 |
|
Election of Director: Jeffrey
Leiden |
|
Management |
|
For |
|
For |
|
| 1.7 |
|
Election of Director: Diana
McKenzie |
|
Management |
|
For |
|
For |
|
| 1.8 |
|
Election of Director: Bruce
Sachs |
|
Management |
|
For |
|
For |
|
| 1.9 |
|
Election of Director: Suketu
Upadhyay |
|
Management |
|
For |
|
For |
|
| 2. |
|
Ratification of Ernst &
Young LLP as independent Registered Public Accounting firm for the year ending December 31, 2023. |
|
Management |
|
For |
|
For |
|
| 3. |
|
Advisory vote to approve
named executive office compensation. |
|
Management |
|
For |
|
For |
|
| 4. |
|
Advisory vote on the frequency
of future advisory votes on executive compensation. |
|
Management |
|
1 Year |
|
For |
|
WEST PHARMACEUTICAL SERVICES, INC.
| Security |
955306105 |
Meeting Type |
Annual |
| Ticker Symbol |
WST |
Meeting Date |
25-Apr-2023 |
| Record Date |
03-Mar-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a. |
|
Election of Director: Mark
A. Buthman |
|
Management |
|
For |
|
For |
|
| 1b. |
|
Election of Director: William
F. Feehery |
|
Management |
|
For |
|
For |
|
| 1c. |
|
Election of Director: Robert
F. Friel |
|
Management |
|
For |
|
For |
|
| 1d. |
|
Election of Director: Eric
M. Green |
|
Management |
|
For |
|
For |
|
| 1e. |
|
Election of Director: Thomas
W. Hofmann |
|
Management |
|
For |
|
For |
|
| 1f. |
|
Election of Director: Molly
E. Joseph |
|
Management |
|
For |
|
For |
|
| 1g. |
|
Election of Director: Deborah
L. V. Keller |
|
Management |
|
For |
|
For |
|
| 1h. |
|
Election of Director: Myla
P. Lai-Goldman |
|
Management |
|
For |
|
For |
|
| 1i. |
|
Election of Director: Stephen
H. Lockhart |
|
Management |
|
For |
|
For |
|
| 1j. |
|
Election of Director: Douglas
A. Michels |
|
Management |
|
For |
|
For |
|
| 1k. |
|
Election of Director: Paolo
Pucci |
|
Management |
|
For |
|
For |
|
| 2. |
|
Advisory vote to approve
named executive officer compensation. |
|
Management |
|
For |
|
For |
|
| 3. |
|
To ratify the appointment
of PricewaterhouseCoopers LLP as our independent registered public accounting firm for 2023. |
|
Management |
|
For |
|
For |
|
| 4. |
|
Advisory vote on the frequency
of an advisory vote on executive compensation. |
|
Management |
|
1 Year |
|
For |
|
| 5. |
|
Shareholder proposal regarding
Fair Elections. |
|
Shareholder |
|
For |
|
Against |
|
ZIMMER BIOMET HOLDINGS, INC.
| Security |
98956P102 |
Meeting Type |
Annual |
| Ticker Symbol |
ZBH |
Meeting Date |
12-May-2023 |
| Record Date |
13-Mar-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a. |
|
Election of Director: Christopher
B. Begley |
|
Management |
|
For |
|
For |
|
| 1b. |
|
Election of Director: Betsy
J. Bernard |
|
Management |
|
For |
|
For |
|
| 1c. |
|
Election of Director: Michael
J. Farrell |
|
Management |
|
For |
|
For |
|
| 1d. |
|
Election of Director: Robert
A. Hagemann |
|
Management |
|
For |
|
For |
|
| 1e. |
|
Election of Director: Bryan
C. Hanson |
|
Management |
|
For |
|
For |
|
| 1f. |
|
Election of Director: Arthur
J. Higgins |
|
Management |
|
For |
|
For |
|
| 1g. |
|
Election of Director: Maria
Teresa Hilado |
|
Management |
|
For |
|
For |
|
| 1h. |
|
Election of Director: Syed
Jafry |
|
Management |
|
For |
|
For |
|
| 1i. |
|
Election of Director: Sreelakshmi
Kolli |
|
Management |
|
For |
|
For |
|
| 1j. |
|
Election of Director: Michael
W. Michelson |
|
Management |
|
For |
|
For |
|
| 2. |
|
Ratify the appointment
of PricewaterhouseCoopers LLP as our independent registered public accounting firm for 2023 |
|
Management |
|
For |
|
For |
|
| 3. |
|
Approve, on a non-binding
advisory basis, named executive officer compensation ("Say on Pay") |
|
Management |
|
For |
|
For |
|
| 4. |
|
Approve, on a non-binding
advisory basis, the frequency of future Say on Pay votes |
|
Management |
|
1 Year |
|
For |
|
ZOETIS INC.
| Security |
98978V103 |
Meeting Type |
Annual |
| Ticker Symbol |
ZTS |
Meeting Date |
18-May-2023 |
| Record Date |
24-Mar-2023 |
|
|
| Item |
|
Proposal |
|
Proposed
by |
|
Vote |
|
For/Against
Management |
|
| 1a. |
|
Election of Director: Paul
M. Bisaro |
|
Management |
|
For |
|
For |
|
| 1b. |
|
Election of Director: Vanessa
Broadhurst |
|
Management |
|
For |
|
For |
|
| 1c. |
|
Election of Director: Frank
A. D'Amelio |
|
Management |
|
For |
|
For |
|
| 1d. |
|
Election of Director: Michael
B. McCallister |
|
Management |
|
For |
|
For |
|
| 1e. |
|
Election of Director: Gregory
Norden |
|
Management |
|
For |
|
For |
|
| 1f. |
|
Election of Director: Louise
M. Parent |
|
Management |
|
For |
|
For |
|
| 1g. |
|
Election of Director: Kristin
C. Peck |
|
Management |
|
For |
|
For |
|
| 1h. |
|
Election of Director: Robert
W. Scully |
|
Management |
|
For |
|
For |
|
| 2. |
|
Advisory vote to approve
our executive compensation. |
|
Management |
|
For |
|
For |
|
| 3. |
|
Ratification of appointment
of KPMG LLP as our independent registered public accounting firm for 2023. |
|
Management |
|
For |
|
For |
|
| 4. |
|
Approval of an amendment
to our Restated Certificate of Incorporation to create a right to call a special meeting. |
|
Management |
|
For |
|
For |
|
| 5. |
|
Shareholder proposal regarding
ability to call a special meeting. |
|
Shareholder |
|
Against |
|
For |
|
SIGNATURES
Pursuant to the requirements of the Investment
Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| (Registrant) |
Tekla Healthcare Opportunites Fund |
|
| |
|
|
| By (Signature and Title)* |
|
| |
|
|
| |
/s/ Daniel R. Omstead |
|
| |
(Daniel R. Omstead, President) |
|
| |
|
|
| Date |
8/4/23 |
|
| |
|
|
|
|
*Print the name and title of each signing officer under his or her
signature.
abrdn Healthcare Opportu... (NYSE:THQ)
Historical Stock Chart
From Oct 2024 to Nov 2024
abrdn Healthcare Opportu... (NYSE:THQ)
Historical Stock Chart
From Nov 2023 to Nov 2024
